JP2002520618A - タンパク質のアレイおよびその使用方法 - Google Patents
タンパク質のアレイおよびその使用方法Info
- Publication number
- JP2002520618A JP2002520618A JP2000560449A JP2000560449A JP2002520618A JP 2002520618 A JP2002520618 A JP 2002520618A JP 2000560449 A JP2000560449 A JP 2000560449A JP 2000560449 A JP2000560449 A JP 2000560449A JP 2002520618 A JP2002520618 A JP 2002520618A
- Authority
- JP
- Japan
- Prior art keywords
- array
- protein
- proteins
- substrate
- immobilized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003498 protein array Methods 0.000 title claims abstract description 28
- 238000001814 protein method Methods 0.000 title description 4
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 376
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 355
- 239000000758 substrate Substances 0.000 claims abstract description 133
- 238000000034 method Methods 0.000 claims abstract description 92
- 239000010409 thin film Substances 0.000 claims abstract description 80
- 238000012216 screening Methods 0.000 claims abstract description 22
- 238000000576 coating method Methods 0.000 claims description 86
- 239000011248 coating agent Substances 0.000 claims description 80
- 239000002356 single layer Substances 0.000 claims description 74
- 230000027455 binding Effects 0.000 claims description 61
- 210000004027 cell Anatomy 0.000 claims description 52
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 45
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 44
- 125000000524 functional group Chemical group 0.000 claims description 44
- 230000003993 interaction Effects 0.000 claims description 33
- 108010058683 Immobilized Proteins Proteins 0.000 claims description 27
- 239000010408 film Substances 0.000 claims description 26
- 239000013545 self-assembled monolayer Substances 0.000 claims description 21
- 239000012491 analyte Substances 0.000 claims description 20
- 239000002094 self assembled monolayer Substances 0.000 claims description 20
- 239000000427 antigen Substances 0.000 claims description 18
- 108091007433 antigens Proteins 0.000 claims description 18
- 102000036639 antigens Human genes 0.000 claims description 18
- 229920000642 polymer Polymers 0.000 claims description 18
- 229910052710 silicon Inorganic materials 0.000 claims description 18
- 239000010703 silicon Substances 0.000 claims description 18
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 16
- -1 phosphorus compound Chemical class 0.000 claims description 16
- 230000000717 retained effect Effects 0.000 claims description 14
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 13
- 239000004365 Protease Substances 0.000 claims description 9
- 239000012530 fluid Substances 0.000 claims description 9
- 239000011521 glass Substances 0.000 claims description 9
- 238000010348 incorporation Methods 0.000 claims description 8
- 108091005804 Peptidases Proteins 0.000 claims description 7
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 6
- 235000012239 silicon dioxide Nutrition 0.000 claims description 6
- 125000006850 spacer group Chemical group 0.000 claims description 6
- 150000001336 alkenes Chemical group 0.000 claims description 5
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 claims description 5
- 229910000510 noble metal Inorganic materials 0.000 claims description 5
- BPUBBGLMJRNUCC-UHFFFAOYSA-N oxygen(2-);tantalum(5+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Ta+5].[Ta+5] BPUBBGLMJRNUCC-UHFFFAOYSA-N 0.000 claims description 5
- 229910001936 tantalum oxide Inorganic materials 0.000 claims description 5
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims description 4
- 241000711549 Hepacivirus C Species 0.000 claims description 4
- 239000012636 effector Substances 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- 150000003573 thiols Chemical class 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 3
- 239000012948 isocyanate Substances 0.000 claims description 3
- 150000002513 isocyanates Chemical class 0.000 claims description 3
- 150000002540 isothiocyanates Chemical class 0.000 claims description 3
- ZDHXKXAHOVTTAH-UHFFFAOYSA-N trichlorosilane Chemical compound Cl[SiH](Cl)Cl ZDHXKXAHOVTTAH-UHFFFAOYSA-N 0.000 claims description 3
- 239000005052 trichlorosilane Substances 0.000 claims description 3
- 102100026398 Cyclic AMP-responsive element-binding protein 3 Human genes 0.000 claims description 2
- 102000004127 Cytokines Human genes 0.000 claims description 2
- 108090000695 Cytokines Proteins 0.000 claims description 2
- 238000012270 DNA recombination Methods 0.000 claims description 2
- 230000033616 DNA repair Effects 0.000 claims description 2
- 102000052510 DNA-Binding Proteins Human genes 0.000 claims description 2
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims description 2
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims description 2
- 108010010369 HIV Protease Proteins 0.000 claims description 2
- 108050008339 Heat Shock Transcription Factor Proteins 0.000 claims description 2
- 102000000039 Heat Shock Transcription Factor Human genes 0.000 claims description 2
- 102000009331 Homeodomain Proteins Human genes 0.000 claims description 2
- 108010048671 Homeodomain Proteins Proteins 0.000 claims description 2
- 101000855520 Homo sapiens Cyclic AMP-responsive element-binding protein 3 Proteins 0.000 claims description 2
- 102000004157 Hydrolases Human genes 0.000 claims description 2
- 108090000604 Hydrolases Proteins 0.000 claims description 2
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 claims description 2
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 claims description 2
- 102000001253 Protein Kinase Human genes 0.000 claims description 2
- 102000008847 Serpin Human genes 0.000 claims description 2
- 108050000761 Serpin Proteins 0.000 claims description 2
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 claims description 2
- 102000040945 Transcription factor Human genes 0.000 claims description 2
- 108091023040 Transcription factor Proteins 0.000 claims description 2
- 101710185494 Zinc finger protein Proteins 0.000 claims description 2
- 102100023597 Zinc finger protein 816 Human genes 0.000 claims description 2
- 150000003862 amino acid derivatives Chemical class 0.000 claims description 2
- 230000006907 apoptotic process Effects 0.000 claims description 2
- 108010057085 cytokine receptors Proteins 0.000 claims description 2
- XIMIGUBYDJDCKI-UHFFFAOYSA-N diselenium Chemical compound [Se]=[Se] XIMIGUBYDJDCKI-UHFFFAOYSA-N 0.000 claims description 2
- 108091008039 hormone receptors Proteins 0.000 claims description 2
- 230000004068 intracellular signaling Effects 0.000 claims description 2
- 150000002527 isonitriles Chemical class 0.000 claims description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 108060006633 protein kinase Proteins 0.000 claims description 2
- 150000003346 selenoethers Chemical class 0.000 claims description 2
- 150000003958 selenols Chemical class 0.000 claims description 2
- 239000003001 serine protease inhibitor Substances 0.000 claims description 2
- 108020003113 steroid hormone receptors Proteins 0.000 claims description 2
- 102000005969 steroid hormone receptors Human genes 0.000 claims description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims 1
- 102000015404 Amino Acid Receptors Human genes 0.000 claims 1
- 101710096438 DNA-binding protein Proteins 0.000 claims 1
- 108010009202 Growth Factor Receptors Proteins 0.000 claims 1
- 102000009465 Growth Factor Receptors Human genes 0.000 claims 1
- 101001100204 Homo sapiens Ras-related protein Rab-40A-like Proteins 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 102100038416 Ras-related protein Rab-40A-like Human genes 0.000 claims 1
- ZOOODBUHSVUZEM-UHFFFAOYSA-N ethoxymethanedithioic acid Chemical compound CCOC(S)=S ZOOODBUHSVUZEM-UHFFFAOYSA-N 0.000 claims 1
- 229940067606 lecithin Drugs 0.000 claims 1
- 235000010445 lecithin Nutrition 0.000 claims 1
- 239000000787 lecithin Substances 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims 1
- 150000003003 phosphines Chemical class 0.000 claims 1
- 150000003558 thiocarbamic acid derivatives Chemical class 0.000 claims 1
- 239000012991 xanthate Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 15
- 238000000338 in vitro Methods 0.000 abstract description 13
- 238000009509 drug development Methods 0.000 abstract description 4
- 235000018102 proteins Nutrition 0.000 description 316
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 39
- 239000012634 fragment Substances 0.000 description 36
- 235000001014 amino acid Nutrition 0.000 description 35
- 150000001413 amino acids Chemical class 0.000 description 35
- 239000000243 solution Substances 0.000 description 33
- 239000000523 sample Substances 0.000 description 29
- 108090000765 processed proteins & peptides Proteins 0.000 description 26
- 239000010410 layer Substances 0.000 description 25
- 238000003491 array Methods 0.000 description 22
- 239000003795 chemical substances by application Substances 0.000 description 20
- 239000011780 sodium chloride Substances 0.000 description 19
- 241000588724 Escherichia coli Species 0.000 description 18
- 230000015572 biosynthetic process Effects 0.000 description 18
- 238000001514 detection method Methods 0.000 description 18
- 239000010931 gold Substances 0.000 description 18
- 239000000463 material Substances 0.000 description 17
- 239000000126 substance Substances 0.000 description 17
- 150000001875 compounds Chemical class 0.000 description 16
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 16
- 229910052737 gold Inorganic materials 0.000 description 16
- 102000004196 processed proteins & peptides Human genes 0.000 description 14
- 241001515965 unidentified phage Species 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 13
- 239000006166 lysate Substances 0.000 description 13
- 229940079593 drug Drugs 0.000 description 12
- 239000003814 drug Substances 0.000 description 12
- 238000005516 engineering process Methods 0.000 description 12
- 108020001507 fusion proteins Proteins 0.000 description 12
- 102000037865 fusion proteins Human genes 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 11
- 229910052751 metal Inorganic materials 0.000 description 11
- 239000002184 metal Substances 0.000 description 11
- 238000002823 phage display Methods 0.000 description 11
- 229920001184 polypeptide Polymers 0.000 description 11
- 108010076667 Caspases Proteins 0.000 description 10
- 230000004927 fusion Effects 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 239000001488 sodium phosphate Substances 0.000 description 10
- 229910000162 sodium phosphate Inorganic materials 0.000 description 10
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 10
- 102000011727 Caspases Human genes 0.000 description 9
- 108060003951 Immunoglobulin Proteins 0.000 description 9
- 239000000872 buffer Substances 0.000 description 9
- 238000010367 cloning Methods 0.000 description 9
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 9
- 102000018358 immunoglobulin Human genes 0.000 description 9
- 230000003287 optical effect Effects 0.000 description 9
- 239000002953 phosphate buffered saline Substances 0.000 description 9
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- UMCMPZBLKLEWAF-BCTGSCMUSA-N 3-[(3-cholamidopropyl)dimethylammonio]propane-1-sulfonate Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCC[N+](C)(C)CCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 UMCMPZBLKLEWAF-BCTGSCMUSA-N 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 8
- 239000000232 Lipid Bilayer Substances 0.000 description 8
- 238000001727 in vivo Methods 0.000 description 8
- 230000002779 inactivation Effects 0.000 description 8
- 230000009871 nonspecific binding Effects 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 7
- 239000007990 PIPES buffer Substances 0.000 description 7
- 108090000284 Pepsin A Proteins 0.000 description 7
- 102000057297 Pepsin A Human genes 0.000 description 7
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 7
- 238000013459 approach Methods 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 7
- 239000013604 expression vector Substances 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- 239000010936 titanium Substances 0.000 description 7
- 229910052719 titanium Inorganic materials 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 6
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 229940000406 drug candidate Drugs 0.000 description 6
- 238000010828 elution Methods 0.000 description 6
- 125000005647 linker group Chemical group 0.000 description 6
- 210000004962 mammalian cell Anatomy 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 229940111202 pepsin Drugs 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- 230000004481 post-translational protein modification Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- MYRGPKHNOBYFOG-UHFFFAOYSA-N O=C1CCC(=O)N1C(C(=O)O)CCCCCCCCCSSCCCCCCCCCC(C(O)=O)N1C(=O)CCC1=O Chemical compound O=C1CCC(=O)N1C(C(=O)O)CCCCCCCCCSSCCCCCCCCCC(C(O)=O)N1C(=O)CCC1=O MYRGPKHNOBYFOG-UHFFFAOYSA-N 0.000 description 5
- 102000035195 Peptidases Human genes 0.000 description 5
- 108010039918 Polylysine Proteins 0.000 description 5
- 101710120037 Toxin CcdB Proteins 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 229910052802 copper Inorganic materials 0.000 description 5
- 239000010949 copper Substances 0.000 description 5
- 235000018417 cysteine Nutrition 0.000 description 5
- 239000013024 dilution buffer Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 238000011065 in-situ storage Methods 0.000 description 5
- 239000003446 ligand Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 210000002381 plasma Anatomy 0.000 description 5
- 229920000656 polylysine Polymers 0.000 description 5
- 210000002729 polyribosome Anatomy 0.000 description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
- 235000019419 proteases Nutrition 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 108010090804 Streptavidin Proteins 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000012148 binding buffer Substances 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 238000012512 characterization method Methods 0.000 description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 238000000151 deposition Methods 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 238000000572 ellipsometry Methods 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 238000000703 high-speed centrifugation Methods 0.000 description 4
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 4
- 235000014304 histidine Nutrition 0.000 description 4
- 210000005260 human cell Anatomy 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 230000003834 intracellular effect Effects 0.000 description 4
- 239000013554 lipid monolayer Substances 0.000 description 4
- 238000000464 low-speed centrifugation Methods 0.000 description 4
- 235000018977 lysine Nutrition 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 238000000206 photolithography Methods 0.000 description 4
- 229920001308 poly(aminoacid) Polymers 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 238000001742 protein purification Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000012521 purified sample Substances 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000013049 sediment Substances 0.000 description 4
- 238000010257 thawing Methods 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 206010003445 Ascites Diseases 0.000 description 3
- 102100035904 Caspase-1 Human genes 0.000 description 3
- 108090000426 Caspase-1 Proteins 0.000 description 3
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 3
- 238000000018 DNA microarray Methods 0.000 description 3
- 102000016911 Deoxyribonucleases Human genes 0.000 description 3
- 108010053770 Deoxyribonucleases Proteins 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000724791 Filamentous phage Species 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 3
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 238000003820 Medium-pressure liquid chromatography Methods 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 108090000526 Papain Proteins 0.000 description 3
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 3
- 108010026552 Proteome Proteins 0.000 description 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 3
- 229910052581 Si3N4 Inorganic materials 0.000 description 3
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 150000001299 aldehydes Chemical group 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- 235000009697 arginine Nutrition 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 229910052804 chromium Inorganic materials 0.000 description 3
- 239000011651 chromium Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000007877 drug screening Methods 0.000 description 3
- 239000003596 drug target Substances 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000013613 expression plasmid Substances 0.000 description 3
- 239000005090 green fluorescent protein Substances 0.000 description 3
- 239000011229 interlayer Substances 0.000 description 3
- 239000000395 magnesium oxide Substances 0.000 description 3
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 3
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 238000004091 panning Methods 0.000 description 3
- 229920002120 photoresistant polymer Polymers 0.000 description 3
- 238000005240 physical vapour deposition Methods 0.000 description 3
- 230000004962 physiological condition Effects 0.000 description 3
- 238000004375 physisorption Methods 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 108091033319 polynucleotide Proteins 0.000 description 3
- 102000040430 polynucleotide Human genes 0.000 description 3
- 239000002157 polynucleotide Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000010453 quartz Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 210000001995 reticulocyte Anatomy 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 238000001338 self-assembly Methods 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 description 3
- 229910052814 silicon oxide Inorganic materials 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- ZVJYVLSWSYMCMF-UHFFFAOYSA-N 11-(10-carboxydecyldisulfanyl)undecanoic acid Chemical compound OC(=O)CCCCCCCCCCSSCCCCCCCCCCC(O)=O ZVJYVLSWSYMCMF-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 101710132601 Capsid protein Proteins 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 101710094648 Coat protein Proteins 0.000 description 2
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 108091060211 Expressed sequence tag Proteins 0.000 description 2
- 108010074860 Factor Xa Proteins 0.000 description 2
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 2
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 2
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 108090001090 Lectins Proteins 0.000 description 2
- 102000004856 Lectins Human genes 0.000 description 2
- 101710125418 Major capsid protein Proteins 0.000 description 2
- 108010052285 Membrane Proteins Proteins 0.000 description 2
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 108091060545 Nonsense suppressor Proteins 0.000 description 2
- 101710141454 Nucleoprotein Proteins 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 101710083689 Probable capsid protein Proteins 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 101710137500 T7 RNA polymerase Proteins 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 108091005764 adaptor proteins Proteins 0.000 description 2
- 102000035181 adaptor proteins Human genes 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 150000001345 alkine derivatives Chemical class 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000000423 cell based assay Methods 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 230000006037 cell lysis Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000002967 competitive immunoassay Methods 0.000 description 2
- 230000009260 cross reactivity Effects 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000001312 dry etching Methods 0.000 description 2
- 238000004070 electrodeposition Methods 0.000 description 2
- 238000005566 electron beam evaporation Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 2
- 235000013861 fat-free Nutrition 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000013595 glycosylation Effects 0.000 description 2
- 238000006206 glycosylation reaction Methods 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 238000013537 high throughput screening Methods 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 230000003100 immobilizing effect Effects 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000007641 inkjet printing Methods 0.000 description 2
- 239000002523 lectin Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
- 108010056929 lyticase Proteins 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000000813 microcontact printing Methods 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 230000036963 noncompetitive effect Effects 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 108700010839 phage proteins Proteins 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 238000000623 plasma-assisted chemical vapour deposition Methods 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 108010011110 polyarginine Proteins 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920000307 polymer substrate Polymers 0.000 description 2
- 238000003752 polymerase chain reaction Methods 0.000 description 2
- 229920006324 polyoxymethylene Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 230000004952 protein activity Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 238000010187 selection method Methods 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 238000000427 thin-film deposition Methods 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 235000002374 tyrosine Nutrition 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 238000003631 wet chemical etching Methods 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- ZMZRKOASUWINDA-VEABSNGSSA-N (4s)-4-[[(2s)-2-amino-3-carboxypropanoyl]amino]-5-[[(2s)-1-[[(2s)-1-carboxy-3-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-oxopentanoic acid Chemical compound OC(=O)C[C@@H](C=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(O)=O ZMZRKOASUWINDA-VEABSNGSSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 1
- YUDSXCHAAXYRGX-UHFFFAOYSA-N 1-(trifluoromethyl)diaziridine Chemical compound FC(F)(F)N1CN1 YUDSXCHAAXYRGX-UHFFFAOYSA-N 0.000 description 1
- IUDGNRWYNOEIKF-UHFFFAOYSA-N 11-bromo-undecanoic acid Chemical compound OC(=O)CCCCCCCCCCBr IUDGNRWYNOEIKF-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- FMYBFLOWKQRBST-UHFFFAOYSA-N 2-[bis(carboxymethyl)amino]acetic acid;nickel Chemical compound [Ni].OC(=O)CN(CC(O)=O)CC(O)=O FMYBFLOWKQRBST-UHFFFAOYSA-N 0.000 description 1
- IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 description 1
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 240000005020 Acaciella glauca Species 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 208000002109 Argyria Diseases 0.000 description 1
- JBRZTFJDHDCESZ-UHFFFAOYSA-N AsGa Chemical compound [As]#[Ga] JBRZTFJDHDCESZ-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 229910001020 Au alloy Inorganic materials 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102100025752 CASP8 and FADD-like apoptosis regulator Human genes 0.000 description 1
- 101710100501 CASP8 and FADD-like apoptosis regulator Proteins 0.000 description 1
- 101100228196 Caenorhabditis elegans gly-4 gene Proteins 0.000 description 1
- 101100459438 Caenorhabditis elegans nac-1 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 101710167800 Capsid assembly scaffolding protein Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 102000004018 Caspase 6 Human genes 0.000 description 1
- 108090000425 Caspase 6 Proteins 0.000 description 1
- 102000017063 Catecholamine Receptors Human genes 0.000 description 1
- 108010013659 Catecholamine Receptors Proteins 0.000 description 1
- 241000511343 Chondrostoma nasus Species 0.000 description 1
- 102100026735 Coagulation factor VIII Human genes 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 108010037464 Cyclooxygenase 1 Proteins 0.000 description 1
- 108010037462 Cyclooxygenase 2 Proteins 0.000 description 1
- 102000005927 Cysteine Proteases Human genes 0.000 description 1
- 108010005843 Cysteine Proteases Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 108010008177 Fd immunoglobulins Proteins 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000005720 Glutathione transferase Human genes 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 1
- 241000235058 Komagataella pastoris Species 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108090000590 Neurotransmitter Receptors Proteins 0.000 description 1
- 102000004108 Neurotransmitter Receptors Human genes 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- BXEFQPCKQSTMKA-UHFFFAOYSA-N OC(=O)C=[N+]=[N-] Chemical compound OC(=O)C=[N+]=[N-] BXEFQPCKQSTMKA-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 101710160107 Outer membrane protein A Proteins 0.000 description 1
- 101150003085 Pdcl gene Proteins 0.000 description 1
- 229920001665 Poly-4-vinylphenol Polymers 0.000 description 1
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 101710193132 Pre-hexon-linking protein VIII Proteins 0.000 description 1
- 101710130420 Probable capsid assembly scaffolding protein Proteins 0.000 description 1
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 101710204410 Scaffold protein Proteins 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- WOUIMBGNEUWXQG-VKHMYHEASA-N Ser-Gly Chemical compound OC[C@H](N)C(=O)NCC(O)=O WOUIMBGNEUWXQG-VKHMYHEASA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 206010042566 Superinfection Diseases 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- GNVMUORYQLCPJZ-UHFFFAOYSA-M Thiocarbamate Chemical compound NC([S-])=O GNVMUORYQLCPJZ-UHFFFAOYSA-M 0.000 description 1
- 102100036407 Thioredoxin Human genes 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000001015 X-ray lithography Methods 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 108091006055 affinity-tagged proteins Proteins 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- HAXFWIACAGNFHA-UHFFFAOYSA-N aldrithiol Chemical compound C=1C=CC=NC=1SSC1=CC=CC=N1 HAXFWIACAGNFHA-UHFFFAOYSA-N 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 125000005376 alkyl siloxane group Chemical group 0.000 description 1
- 150000001356 alkyl thiols Chemical class 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000012062 aqueous buffer Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000001484 arginines Chemical class 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 150000001503 aryl iodides Chemical class 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 108010051758 aspartyl-glutamyl-valyl-aspartal Proteins 0.000 description 1
- 239000012131 assay buffer Substances 0.000 description 1
- 125000000751 azo group Chemical group [*]N=N[*] 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 239000006177 biological buffer Substances 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000013590 bulk material Substances 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- KDJVUTSOHYQCDQ-UHFFFAOYSA-N carbamic acid;1h-imidazole Chemical compound NC([O-])=O.[NH2+]1C=CN=C1 KDJVUTSOHYQCDQ-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000001735 carboxylic acids Chemical group 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000006721 cell death pathway Effects 0.000 description 1
- 230000007910 cell fusion Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000003196 chaotropic effect Effects 0.000 description 1
- 238000005229 chemical vapour deposition Methods 0.000 description 1
- 102000021178 chitin binding proteins Human genes 0.000 description 1
- 108091011157 chitin binding proteins Proteins 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000011960 computer-aided design Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 239000005289 controlled pore glass Substances 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 150000001945 cysteines Chemical class 0.000 description 1
- 102000003675 cytokine receptors Human genes 0.000 description 1
- 125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 239000012933 diacyl peroxide Substances 0.000 description 1
- 125000004989 dicarbonyl group Chemical group 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 150000002019 disulfides Chemical class 0.000 description 1
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 1
- 238000012912 drug discovery process Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005370 electroosmosis Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 229920006335 epoxy glue Polymers 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 108010036236 extracellular matrix receptor Proteins 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000002143 fast-atom bombardment mass spectrum Methods 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- XUCNUKMRBVNAPB-UHFFFAOYSA-N fluoroethene Chemical group FC=C XUCNUKMRBVNAPB-UHFFFAOYSA-N 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 1
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 1
- 239000003353 gold alloy Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 125000005179 haloacetyl group Chemical group 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000012203 high throughput assay Methods 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 230000017730 intein-mediated protein splicing Effects 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000002687 intercalation Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229960003151 mercaptamine Drugs 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 238000004377 microelectronic Methods 0.000 description 1
- 238000001053 micromoulding Methods 0.000 description 1
- 210000001589 microsome Anatomy 0.000 description 1
- PYLWMHQQBFSUBP-UHFFFAOYSA-N monofluorobenzene Chemical compound FC1=CC=CC=C1 PYLWMHQQBFSUBP-UHFFFAOYSA-N 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 description 1
- 229960000210 nalidixic acid Drugs 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 210000001322 periplasm Anatomy 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 230000002186 photoactivation Effects 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920000724 poly(L-arginine) polymer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 108091005626 post-translationally modified proteins Proteins 0.000 description 1
- 102000035123 post-translationally modified proteins Human genes 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000012743 protein tagging Effects 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000003499 redwood Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 150000003376 silicon Chemical class 0.000 description 1
- 229910052990 silicon hydride Inorganic materials 0.000 description 1
- 238000005549 size reduction Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004960 subcellular localization Effects 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 150000004992 toluidines Chemical class 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/0061—The surface being organic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00612—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports the surface being inorganic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00614—Delimitation of the attachment areas
- B01J2219/00617—Delimitation of the attachment areas by chemical means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00614—Delimitation of the attachment areas
- B01J2219/00617—Delimitation of the attachment areas by chemical means
- B01J2219/00619—Delimitation of the attachment areas by chemical means using hydrophilic or hydrophobic regions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00614—Delimitation of the attachment areas
- B01J2219/00621—Delimitation of the attachment areas by physical means, e.g. trenches, raised areas
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00623—Immobilisation or binding
- B01J2219/00626—Covalent
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00623—Immobilisation or binding
- B01J2219/0063—Other, e.g. van der Waals forces, hydrogen bonding
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00632—Introduction of reactive groups to the surface
- B01J2219/00635—Introduction of reactive groups to the surface by reactive plasma treatment
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00605—Making arrays on substantially continuous surfaces the compounds being directly bound or immobilised to solid supports
- B01J2219/00632—Introduction of reactive groups to the surface
- B01J2219/00637—Introduction of reactive groups to the surface by coating it with another layer
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00639—Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium
- B01J2219/00641—Making arrays on substantially continuous surfaces the compounds being trapped in or bound to a porous medium the porous medium being continuous, e.g. porous oxide substrates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00603—Making arrays on substantially continuous surfaces
- B01J2219/00659—Two-dimensional arrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/0068—Means for controlling the apparatus of the process
- B01J2219/00702—Processes involving means for analysing and characterising the products
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00725—Peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Nanotechnology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Materials Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Computational Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Composite Materials (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/115,455 | 1998-07-14 | ||
| US09/115,455 US6406921B1 (en) | 1998-07-14 | 1998-07-14 | Protein arrays for high-throughput screening |
| PCT/US1999/015971 WO2000004382A1 (en) | 1998-07-14 | 1999-07-14 | Arrays of proteins and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002520618A true JP2002520618A (ja) | 2002-07-09 |
| JP2002520618A5 JP2002520618A5 (enExample) | 2007-05-24 |
Family
ID=22361520
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000560449A Pending JP2002520618A (ja) | 1998-07-14 | 1999-07-14 | タンパク質のアレイおよびその使用方法 |
| JP2000560456A Pending JP2002520620A (ja) | 1998-07-14 | 1999-07-14 | タンパク質−捕捉剤のアレイおよびその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000560456A Pending JP2002520620A (ja) | 1998-07-14 | 1999-07-14 | タンパク質−捕捉剤のアレイおよびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (14) | US6406921B1 (enExample) |
| EP (2) | EP1097380A1 (enExample) |
| JP (2) | JP2002520618A (enExample) |
| AT (1) | ATE397752T1 (enExample) |
| AU (2) | AU773068B2 (enExample) |
| CA (2) | CA2337075A1 (enExample) |
| DE (1) | DE69938867D1 (enExample) |
| WO (2) | WO2000004382A1 (enExample) |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005312425A (ja) * | 2004-03-31 | 2005-11-10 | Toyo Kohan Co Ltd | ポリペプチドを固定化する方法、ポリペプチドが固定化されてなる固体支持体、これを用いたポリペプチドの検出方法及び精製方法、ならびにポリペプチドを固定化するための固体支持体 |
| JP2005535909A (ja) * | 2002-08-16 | 2005-11-24 | ディシジョン バイオマーカーズ インコーポレイテッド | 材料の分離、反応、および顕微鏡分析のための基板 |
| JP2006208012A (ja) * | 2005-01-25 | 2006-08-10 | Toray Ind Inc | 選択結合性物質固定化担体 |
| WO2007055288A1 (ja) * | 2005-11-10 | 2007-05-18 | National University Of Corporation Hiroshima University | 酸化ケイ素含有物質に結合するタンパク質を介したタンパク質の固定化方法および固定化剤 |
| JP2008105973A (ja) * | 2006-10-24 | 2008-05-08 | Toyo Kohan Co Ltd | ポリペプチド固定化担体の保存方法 |
| KR100836206B1 (ko) | 2007-03-20 | 2008-06-09 | 연세대학교 산학협력단 | 패턴형성용 폴리에틸렌글리콜 하이드로젤과 이의 제조방법 |
| JP2009510423A (ja) * | 2005-09-27 | 2009-03-12 | サントル・ナシオナル・ドゥ・ラ・ルシェルシュ・シアンティフィーク(セーエヌエールエス) | 表面プラズモン共鳴(spr)検出用の新規チップ |
| JP2009542203A (ja) * | 2006-06-27 | 2009-12-03 | コリア リサーチ インスティチュート オブ バイオサイエンス アンド バイオテクノロジー | システインタグ付きブドウ球菌タンパク質g変異体 |
| WO2011089903A1 (en) * | 2010-01-25 | 2011-07-28 | Panasonic Corporation | A method for immobilizing protein a on a self-assembled monolayer |
| WO2012029202A1 (en) * | 2010-08-30 | 2012-03-08 | Panasonic Corporation | A method for immobilizing streptavidin on a self-assembled monolayer |
| WO2012053138A1 (ja) * | 2010-10-19 | 2012-04-26 | パナソニック株式会社 | グルコースオキシダーゼを自己組織化膜上に固定する方法 |
| US8372596B2 (en) | 2005-11-10 | 2013-02-12 | National University Of Corporation Hiroshima University | Asbestos detection method, asbestos detection agent, asbestos detection kit, method for screening candidate for agent aiming at preventing or treating disease for which asbestos is causative or worsening factor |
| JP2018004476A (ja) * | 2016-07-04 | 2018-01-11 | 花王株式会社 | タンパク質解析用固相担体及びその製造方法 |
| JP2019035760A (ja) * | 2012-02-07 | 2019-03-07 | ヴィブラント ホールディングス リミテッド ライアビリティ カンパニー | 基板、ペプチドアレイ、および方法 |
| US11168365B2 (en) | 2017-05-26 | 2021-11-09 | Vibrant Holdings, Llc | Photoactive compounds and methods for biomolecule detection and sequencing |
| US11674956B2 (en) | 2012-09-28 | 2023-06-13 | Vibrant Holdings, Llc | Methods, systems, and arrays for biomolecular analysis |
| US12251674B2 (en) | 2012-11-14 | 2025-03-18 | Vibrant Holdings, Llc | Substrates, systems, and methods for array synthesis and biomolecular analysis |
| US12319712B2 (en) | 2018-05-09 | 2025-06-03 | Vibrant Holdings, Llc | Methods of synthesizing a polynucleotide array using photoactivated agents |
Families Citing this family (776)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5776748A (en) * | 1993-10-04 | 1998-07-07 | President And Fellows Of Harvard College | Method of formation of microstamped patterns on plates for adhesion of cells and other biological materials, devices and uses therefor |
| CA2242582A1 (en) * | 1996-02-16 | 1997-08-21 | Smith & Nephew Endoscopy, Inc. | Graft anchor |
| ES2288760T3 (es) | 1996-04-25 | 2008-01-16 | Bioarray Solutions Ltd. | Ensamblaje electrocinetico controlado por luz de particulas proximas a superficies. |
| US7041510B2 (en) * | 1996-04-25 | 2006-05-09 | Bioarray Solutions Ltd. | System and method for programmable illumination pattern generation |
| JP4245664B2 (ja) | 1996-07-29 | 2009-03-25 | ナノスフェアー インコーポレイテッド | オリゴヌクレオチドを備えた金ナノ粒子を使用して標的該酸を検出する方法 |
| US6750016B2 (en) | 1996-07-29 | 2004-06-15 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| US7098320B1 (en) | 1996-07-29 | 2006-08-29 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| US6506564B1 (en) * | 1996-07-29 | 2003-01-14 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| US6767702B2 (en) * | 1996-07-29 | 2004-07-27 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| US6984491B2 (en) | 1996-07-29 | 2006-01-10 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| US7169556B2 (en) | 1996-07-29 | 2007-01-30 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| US6582921B2 (en) | 1996-07-29 | 2003-06-24 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses thereof |
| US6368877B1 (en) * | 1997-06-25 | 2002-04-09 | Massachusetts Institute Of Technology | Self-assembling peptide surfaces for cell patterning and interactions |
| US20050037397A1 (en) * | 2001-03-28 | 2005-02-17 | Nanosphere, Inc. | Bio-barcode based detection of target analytes |
| US6974669B2 (en) * | 2000-03-28 | 2005-12-13 | Nanosphere, Inc. | Bio-barcodes based on oligonucleotide-modified nanoparticles |
| CA2316966C (en) | 1997-12-17 | 2008-04-08 | Horst Vogel | Positioning and electrophysiological characterization of individual cells and reconstituted membrane systems on microstructured carriers |
| US20020144905A1 (en) * | 1997-12-17 | 2002-10-10 | Christian Schmidt | Sample positioning and analysis system |
| US7244349B2 (en) | 1997-12-17 | 2007-07-17 | Molecular Devices Corporation | Multiaperture sample positioning and analysis system |
| WO1999039210A1 (en) * | 1998-01-29 | 1999-08-05 | Miller, Samuel | High density arrays for proteome analysis and methods and compositions therefor |
| AU2583899A (en) | 1998-02-04 | 1999-08-23 | Invitrogen Corporation | Microarrays and uses therefor |
| GB9812783D0 (en) | 1998-06-12 | 1998-08-12 | Cenes Ltd | High throuoghput screen |
| US6576478B1 (en) * | 1998-07-14 | 2003-06-10 | Zyomyx, Inc. | Microdevices for high-throughput screening of biomolecules |
| US6406921B1 (en) * | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
| US20030138973A1 (en) * | 1998-07-14 | 2003-07-24 | Peter Wagner | Microdevices for screening biomolecules |
| US6897073B2 (en) * | 1998-07-14 | 2005-05-24 | Zyomyx, Inc. | Non-specific binding resistant protein arrays and methods for making the same |
| US20020119579A1 (en) * | 1998-07-14 | 2002-08-29 | Peter Wagner | Arrays devices and methods of use thereof |
| US6780582B1 (en) | 1998-07-14 | 2004-08-24 | Zyomyx, Inc. | Arrays of protein-capture agents and methods of use thereof |
| US7132247B1 (en) * | 1998-09-17 | 2006-11-07 | Regents Of The University Of Minnesota | Composite devices incorporating biological material and methods |
| US20030190740A1 (en) * | 1998-10-13 | 2003-10-09 | The University Of Georgia Research Foundation, Inc | Stabilized bioactive peptides and methods of identification, synthesis, and use |
| WO2000022112A1 (en) * | 1998-10-13 | 2000-04-20 | The University Of Georgia Research Foundation, Inc. | Stabilized bioactive peptides and methods of identification, synthesis and use |
| IL143027A0 (en) * | 1998-11-16 | 2002-04-21 | Genway Biotech Inc | Generation of antibodies using polynucleotide vaccination in avian species |
| CN100406890C (zh) | 1998-11-30 | 2008-07-30 | 内诺斯佩尔公司 | 带有聚合物壳的纳米颗粒 |
| US6635311B1 (en) | 1999-01-07 | 2003-10-21 | Northwestern University | Methods utilizing scanning probe microscope tips and products therefor or products thereby |
| US6827979B2 (en) | 1999-01-07 | 2004-12-07 | Northwestern University | Methods utilizing scanning probe microscope tips and products therefor or produced thereby |
| US7166475B2 (en) * | 1999-02-26 | 2007-01-23 | Cyclacel Ltd. | Compositions and methods for monitoring the modification state of a pair of polypeptides |
| AU773291B2 (en) * | 1999-03-10 | 2004-05-20 | Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The | UPA, a universal protein array system |
| AU3867400A (en) * | 1999-03-19 | 2000-10-09 | Duke University | Methods of using bioelastomers |
| DE19916867A1 (de) * | 1999-04-14 | 2000-10-19 | Fraunhofer Ges Forschung | Anordnung und Verfahren zur Herstellung planarer Arrays mit immobilisierten Molekülen |
| US20040053290A1 (en) * | 2000-01-11 | 2004-03-18 | Terbrueggen Robert Henry | Devices and methods for biochip multiplexing |
| US7638464B2 (en) * | 1999-04-26 | 2009-12-29 | Biocept, Inc. | Three dimensional format biochips |
| WO2000067293A1 (en) | 1999-04-29 | 2000-11-09 | Ciphergen Biosystems, Inc. | Sample holder with hydrophobic coating for gas phase mass spectrometers |
| US6690399B1 (en) * | 1999-05-07 | 2004-02-10 | Tropix, Inc. | Data display software for displaying assay results |
| JP4493125B2 (ja) * | 1999-05-07 | 2010-06-30 | 独立行政法人理化学研究所 | 相互作用するタンパク質の検出方法 |
| US6824987B1 (en) * | 1999-05-11 | 2004-11-30 | President And Fellows Of Harvard College | Small molecule printing |
| US7932213B2 (en) * | 1999-05-11 | 2011-04-26 | President And Fellows Of Harvard College | Small molecule printing |
| US20030186311A1 (en) * | 1999-05-21 | 2003-10-02 | Bioforce Nanosciences, Inc. | Parallel analysis of molecular interactions |
| US20020042081A1 (en) * | 2000-10-10 | 2002-04-11 | Eric Henderson | Evaluating binding affinities by force stratification and force panning |
| US6573369B2 (en) | 1999-05-21 | 2003-06-03 | Bioforce Nanosciences, Inc. | Method and apparatus for solid state molecular analysis |
| US20030073250A1 (en) * | 1999-05-21 | 2003-04-17 | Eric Henderson | Method and apparatus for solid state molecular analysis |
| DE60044923D1 (de) * | 1999-05-28 | 2010-10-21 | Yokogawa Electric Corp | Biochip-Lesegerät |
| US7179638B2 (en) * | 1999-07-30 | 2007-02-20 | Large Scale Biology Corporation | Microarrays and their manufacture by slicing |
| AU6834700A (en) * | 1999-08-13 | 2001-03-13 | Zeptosens Ag | Device and method for determining multiple analytes |
| US7167615B1 (en) | 1999-11-05 | 2007-01-23 | Board Of Regents, The University Of Texas System | Resonant waveguide-grating filters and sensors and methods for making and using same |
| US8111401B2 (en) * | 1999-11-05 | 2012-02-07 | Robert Magnusson | Guided-mode resonance sensors employing angular, spectral, modal, and polarization diversity for high-precision sensing in compact formats |
| EP1242460B1 (en) * | 1999-11-29 | 2006-10-18 | Unilever Plc | Immobilisation of proteins using a polypeptide segment |
| IL150291A0 (en) * | 2000-01-11 | 2002-12-01 | Maxygen Inc | Integrated systems and methods for diversity generation and screening |
| DE60142765D1 (de) * | 2000-01-31 | 2010-09-23 | Sense Proteomic Ltd | Verfahren zur herstellung von protein expression arrays und anwendung derselben in schnellem screening |
| WO2001057198A2 (en) * | 2000-01-31 | 2001-08-09 | Sense Proteomic Limited | Methods of generating protein expression arrays and the use thereof in rapid screening |
| US7816098B2 (en) | 2000-01-31 | 2010-10-19 | Sense Proteomic Limited | Methods of making and using a protein array |
| US20080280771A1 (en) * | 2000-02-08 | 2008-11-13 | Regents Of The University Of Michigan | Protein MicroarraySystem |
| US20050230315A1 (en) * | 2003-01-13 | 2005-10-20 | Regents Of The University Of Michigan | Protein microarray system |
| WO2001062887A1 (en) * | 2000-02-23 | 2001-08-30 | Zyomyx, Inc. | Chips having elevated sample surfaces |
| US6897015B2 (en) * | 2000-03-07 | 2005-05-24 | Bioforce Nanosciences, Inc. | Device and method of use for detection and characterization of pathogens and biological materials |
| US6686461B1 (en) | 2000-03-22 | 2004-02-03 | Solulink Bioscience, Inc. | Triphosphate oligonucleotide modification reagents and uses thereof |
| US7102024B1 (en) | 2000-08-01 | 2006-09-05 | Schwartz David A | Functional biopolymer modification reagents and uses thereof |
| US6541071B1 (en) * | 2000-03-23 | 2003-04-01 | Corning Incorporated | Method for fabricating supported bilayer-lipid membranes |
| AU2001252978A1 (en) | 2000-03-27 | 2001-10-08 | Zyomyx, Inc. | Site-specific, covalent bioconjugation of proteins |
| EP1272671A2 (de) * | 2000-03-30 | 2003-01-08 | Infineon Technologies AG | Biosensor, biosensor-array, verfahren zum herstellen einer elektrode eines biosensors, verfahren zum herstellen eines biosensors |
| CA2403296A1 (en) * | 2000-04-10 | 2001-10-18 | Benjamin F. Cravatt | Proteomic analysis using activity-based probe libraries |
| AU2001255436A1 (en) * | 2000-04-17 | 2001-10-30 | Transtech Pharma | Protein expression system arrays and use in biological screening |
| DE10020704B4 (de) * | 2000-04-27 | 2006-09-28 | Bioref Gmbh | Biochip zur Archivierung und labormedizinischen Analyse von biologischem Probenmaterial, Verfahren zu dessen Herstellung sowie dessen Verwendung in diagnostischen Verfahren |
| CN1196798C (zh) | 2000-05-04 | 2005-04-13 | 耶鲁大学 | 用于筛选蛋白活性的高密度蛋白阵列 |
| DE10027397A1 (de) * | 2000-06-02 | 2001-12-13 | Graffinity Pharm Design Gmbh | Oberfläche zur Immobilisierung von Liganden |
| AU2001268173A1 (en) * | 2000-06-05 | 2001-12-17 | Chiron Corporation | Microarrays for performing proteomic analyses |
| US7148058B2 (en) * | 2000-06-05 | 2006-12-12 | Chiron Corporation | Protein microarrays on mirrored surfaces for performing proteomic analyses |
| US7153682B2 (en) * | 2000-06-05 | 2006-12-26 | Chiron Corporation | Microarrays on mirrored substrates for performing proteomic analyses |
| KR100865664B1 (ko) * | 2000-06-14 | 2008-10-29 | 비스타겐 인코포레이티드 | 간 줄기 세포를 사용하는 독성 타이핑 |
| AU2001269906A1 (en) * | 2000-06-19 | 2002-01-02 | Zyomyx, Inc. | Methods for immobilizing polypeptides |
| US9709559B2 (en) | 2000-06-21 | 2017-07-18 | Bioarray Solutions, Ltd. | Multianalyte molecular analysis using application-specific random particle arrays |
| DE60117556T2 (de) | 2000-06-21 | 2006-11-02 | Bioarray Solutions Ltd. | Multianalytische molekularanalyse durch verwendung anwendungsspezifischer zufallspartikelarrays |
| US20020115068A1 (en) * | 2000-06-23 | 2002-08-22 | Ian Tomlinson | Matrix screening method |
| US6829753B2 (en) | 2000-06-27 | 2004-12-07 | Fluidigm Corporation | Microfluidic design automation method and system |
| DE10031587A1 (de) * | 2000-06-29 | 2002-01-10 | Basf Ag | Dosierung von Suspensionen im Mikromaßstab zur Herstellung von Materialproben in der kombinatorischen Materialforschung sowie deren Prüfung |
| US7518724B2 (en) * | 2000-07-11 | 2009-04-14 | Maven Technologies | Image acquisition, processing, and display |
| AU7687001A (en) * | 2000-07-11 | 2002-01-21 | Nanospherre Inc | Method of detection by enhancement of silver staining |
| US7023547B2 (en) * | 2000-07-11 | 2006-04-04 | Maven Technologies, Llc | Apparatus including a biochip for imaging of biological samples and method |
| JP2004504607A (ja) * | 2000-07-19 | 2004-02-12 | ポインティリスト・インコーポレイテッド | ネスト化ソーティングおよびハイスループットスクリーニングのための結合タンパク質およびタグのコレクションならびにそれら使用 |
| WO2002010750A2 (en) * | 2000-07-31 | 2002-02-07 | Maxygen, Inc. | Biosensors, reagents and diagnostic applications of directed evolution |
| WO2002012893A2 (en) * | 2000-08-03 | 2002-02-14 | Massachusetts Institute Of Technology | Microarrays of functional biomolecules, and uses therefor |
| US7270730B2 (en) | 2000-08-04 | 2007-09-18 | Essen Instruments, Inc. | High-throughput electrophysiological measurement system |
| US7067046B2 (en) | 2000-08-04 | 2006-06-27 | Essen Instruments, Inc. | System for rapid chemical activation in high-throughput electrophysiological measurements |
| US7678539B2 (en) | 2000-08-10 | 2010-03-16 | Corning Incorporated | Arrays of biological membranes and methods and use thereof |
| US6977155B2 (en) | 2000-08-10 | 2005-12-20 | Corning Incorporated | Arrays of biological membranes and methods and use thereof |
| US20020048823A1 (en) * | 2000-08-11 | 2002-04-25 | Qianjin Hu | Methods and universal monoclonal antibody array |
| US7244598B2 (en) * | 2000-08-14 | 2007-07-17 | Surface Logix, Inc. | Biomolecule arrays |
| AU2001278613B2 (en) | 2000-08-15 | 2006-09-07 | Discerna Limited | Functional protein arrays |
| DE60135150D1 (de) * | 2000-08-15 | 2008-09-11 | Bioforce Nanosciences Inc | Vorrichtung zur bildung von nanomolekularen netzwerken |
| JP2004509645A (ja) * | 2000-08-17 | 2004-04-02 | センス・プロテオミック・リミテッド | 方法 |
| US7094568B2 (en) | 2000-08-17 | 2006-08-22 | Sense Proteomic Ltd. | Method for producing proteins tagged at the N- or C-terminus |
| EP1184349A1 (en) * | 2000-09-01 | 2002-03-06 | A.S.B.L. Facultes Universitaires Notre-Dame De La Paix | Method for obtaining a surface activation of a solid support for building biochips microarrays |
| US20040115726A1 (en) * | 2001-09-14 | 2004-06-17 | Renpei Nagashima | Method, system, apparatus and device for discovering and preparing chemical compounds for medical and other uses. |
| AU2001286252A1 (en) * | 2000-09-14 | 2002-03-26 | Reverse Proteomics Research Institute Co., Ltd. | Method, system, apparatus and device for discovering and preparing chemical compounds |
| WO2002023163A1 (en) | 2000-09-15 | 2002-03-21 | California Institute Of Technology | Microfabricated crossflow devices and methods |
| GB0022978D0 (en) * | 2000-09-19 | 2000-11-01 | Oxford Glycosciences Uk Ltd | Detection of peptides |
| US7354721B2 (en) | 2000-09-22 | 2008-04-08 | Clontech Laboratories, Inc. | Highly sensitive proteomic analysis methods, and kits and systems for practicing the same |
| US7348182B2 (en) * | 2000-10-03 | 2008-03-25 | Mirari Biosciences, Inc. | Directed microwave chemistry |
| US20040209303A1 (en) * | 2000-10-03 | 2004-10-21 | Martin Mark T. | Methods and compositions for directed microwave chemistry |
| EP1195606A1 (en) * | 2000-10-03 | 2002-04-10 | VBC-Genomics Forschungsges.m.b.H. | Allergen-microarray assay |
| ATE537264T1 (de) * | 2000-10-03 | 2011-12-15 | Mirari Biosciences Inc | Verfahren und zusammensetzungen für die gerichtete mikrowellenchemiie |
| WO2002030486A2 (en) | 2000-10-13 | 2002-04-18 | Fluidigm Corporation | Microfluidic device based sample injection system for analytical devices |
| WO2002045215A2 (en) * | 2000-10-20 | 2002-06-06 | Northwestern University | Nanolithography methods and products therefor and produced thereby |
| EP1409127A2 (en) | 2000-10-24 | 2004-04-21 | Fatemeh Mojtabai | Ordered two- and three-dimensional structures of amphiphilic molecules |
| US20050100951A1 (en) * | 2000-10-26 | 2005-05-12 | Biocept, Inc. | 3D format biochips and method of use |
| US7264973B2 (en) * | 2000-10-30 | 2007-09-04 | Sru Biosystems, Inc. | Label-free methods for performing assays using a colorimetric resonant optical biosensor |
| US7153702B2 (en) * | 2000-10-30 | 2006-12-26 | Sru Biosystems, Inc. | Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor |
| US7142296B2 (en) * | 2000-10-30 | 2006-11-28 | Sru Biosystems, Inc. | Method and apparatus for detecting biomolecular interactions |
| US7300803B2 (en) * | 2000-10-30 | 2007-11-27 | Sru Biosystems, Inc. | Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor |
| US7175980B2 (en) * | 2000-10-30 | 2007-02-13 | Sru Biosystems, Inc. | Method of making a plastic colorimetric resonant biosensor device with liquid handling capabilities |
| US7615339B2 (en) * | 2000-10-30 | 2009-11-10 | Sru Biosystems, Inc. | Method for producing a colorimetric resonant reflection biosensor on rigid surfaces |
| US7371562B2 (en) * | 2000-10-30 | 2008-05-13 | Sru Biosystems, Inc. | Guided mode resonant filter biosensor using a linear grating surface structure |
| US20030092075A1 (en) * | 2000-10-30 | 2003-05-15 | Sru Biosystems, Llc | Aldehyde chemical surface activation processes and test methods for colorimetric resonant sensors |
| US7217574B2 (en) | 2000-10-30 | 2007-05-15 | Sru Biosystems, Inc. | Method and apparatus for biosensor spectral shift detection |
| US7118710B2 (en) * | 2000-10-30 | 2006-10-10 | Sru Biosystems, Inc. | Label-free high-throughput optical technique for detecting biomolecular interactions |
| US7023544B2 (en) | 2000-10-30 | 2006-04-04 | Sru Biosystems, Inc. | Method and instrument for detecting biomolecular interactions |
| US7202076B2 (en) * | 2000-10-30 | 2007-04-10 | Sru Biosystems, Inc. | Label-free high-throughput optical technique for detecting biomolecular interactions |
| US7101660B2 (en) * | 2000-10-30 | 2006-09-05 | Sru Biosystems, Inc. | Method for producing a colorimetric resonant reflection biosensor on rigid surfaces |
| US7875434B2 (en) * | 2000-10-30 | 2011-01-25 | Sru Biosystems, Inc. | Label-free methods for performing assays using a colorimetric resonant reflectance optical biosensor |
| US7306827B2 (en) * | 2000-10-30 | 2007-12-11 | Sru Biosystems, Inc. | Method and machine for replicating holographic gratings on a substrate |
| US7575939B2 (en) | 2000-10-30 | 2009-08-18 | Sru Biosystems, Inc. | Optical detection of label-free biomolecular interactions using microreplicated plastic sensor elements |
| DE10054055A1 (de) * | 2000-10-31 | 2002-05-23 | Nmi Univ Tuebingen | Verfahren zur Analyse von Proteinen |
| US7232109B2 (en) * | 2000-11-06 | 2007-06-19 | California Institute Of Technology | Electrostatic valves for microfluidic devices |
| US20050084908A1 (en) * | 2000-11-06 | 2005-04-21 | Chugai Seiyaku Kabushiki Kaisha | Methods for detecting binding of low-molecular-weight compound and its binding partner molecule |
| US6699665B1 (en) | 2000-11-08 | 2004-03-02 | Surface Logix, Inc. | Multiple array system for integrating bioarrays |
| US7123764B2 (en) | 2000-11-08 | 2006-10-17 | Surface Logix Inc. | Image processing method for use in analyzing data of a chemotaxis or haptotaxis assay |
| US7374906B2 (en) | 2000-11-08 | 2008-05-20 | Surface Logix, Inc. | Biological assays using gradients formed in microfluidic systems |
| EP1334361A2 (de) * | 2000-11-17 | 2003-08-13 | Zeptosens AG | Kit und verfahren zur multianalytbestimmung, mit vorkehrungen zur referenzierung der dichte immobilisierter erkennungselemente |
| JP2002153272A (ja) * | 2000-11-24 | 2002-05-28 | Inst Of Physical & Chemical Res | 生体分子マイクロアレイ |
| EP2202520A1 (en) | 2000-11-27 | 2010-06-30 | Intelligent Medical Devices LLC | Clinically intelligent diagnostic devices and methods |
| US6905816B2 (en) | 2000-11-27 | 2005-06-14 | Intelligent Medical Devices, Inc. | Clinically intelligent diagnostic devices and methods |
| AU2002229639A1 (en) * | 2000-12-13 | 2002-06-24 | De Haard, Johannes Joseph Wilhelmus | Camelidae antibody arrays |
| FR2818287B1 (fr) * | 2000-12-14 | 2003-01-17 | Commissariat Energie Atomique | Support solide pour l'immobilisation d'oligonucleotides |
| WO2002048716A2 (en) | 2000-12-14 | 2002-06-20 | Paul Stroobant | Differential phage capture proteomics |
| US6798521B2 (en) * | 2000-12-29 | 2004-09-28 | Texas Instruments Incorporated | Robust integrated surface plasmon resonance sensor |
| US7205161B2 (en) * | 2001-01-10 | 2007-04-17 | Symyx Technologies, Inc. | Polymer brushes for immobilizing molecules to a surface or substrate having improved stability |
| WO2002082051A2 (en) * | 2001-01-17 | 2002-10-17 | Tubbs Kemmons A | An integrated high throughput system for the analysis of biomolecules |
| EP1360490B1 (en) * | 2001-01-23 | 2011-12-21 | President and Fellows of Harvard College | Nucleic-acid programmable protein arrays |
| US20020169562A1 (en) * | 2001-01-29 | 2002-11-14 | Gregory Stephanopoulos | Defining biological states and related genes, proteins and patterns |
| US7332286B2 (en) | 2001-02-02 | 2008-02-19 | University Of Pennsylvania | Peptide or protein microassay method and apparatus |
| WO2002063280A1 (en) * | 2001-02-06 | 2002-08-15 | Auburn University | Ligand sensor devices and uses thereof |
| JP4797196B2 (ja) | 2001-02-14 | 2011-10-19 | 株式会社 フューエンス | マイクロチップ |
| US6913697B2 (en) * | 2001-02-14 | 2005-07-05 | Science & Technology Corporation @ Unm | Nanostructured separation and analysis devices for biological membranes |
| US20020165675A1 (en) * | 2001-03-03 | 2002-11-07 | Golovlev Valeri V. | Method and microelectronic device for multi-site molecule detection |
| WO2002071067A1 (en) * | 2001-03-07 | 2002-09-12 | Bio-Rad Laboratories, Inc. | Assay system for simultaneous detection and measurement of multiple modified cellular proteins |
| US20020137106A1 (en) * | 2001-03-09 | 2002-09-26 | Ciphergen Biosystems, Inc. | Detection of biological pathway components |
| CA2441086A1 (en) * | 2001-03-19 | 2002-09-26 | Wisconsin Alumni Research Foundation | Identification of gene expression alterations underlying the aging process in mammals |
| EP1370696A4 (en) * | 2001-03-20 | 2009-04-22 | Ortho Clinical Diagnostics Inc | EXPRESSION PROFILES AND METHOD OF USE |
| US20060040286A1 (en) * | 2001-03-28 | 2006-02-23 | Nanosphere, Inc. | Bio-barcode based detection of target analytes |
| AU2002253995A1 (en) * | 2001-03-29 | 2002-10-15 | Hybrigen, Inc. | Improved hybrid gene libraries and uses thereof |
| WO2002081729A2 (en) | 2001-04-06 | 2002-10-17 | California Institute Of Technology | Nucleic acid amplification utilizing microfluidic devices |
| CN1524180A (zh) * | 2001-04-10 | 2004-08-25 | 纽约市哥伦比亚大学信托人 | 新型微列阵及其使用方法 |
| WO2002084252A2 (en) * | 2001-04-17 | 2002-10-24 | Xenoport, Inc. | Epitope-captured antibody display |
| US20040171068A1 (en) * | 2001-04-19 | 2004-09-02 | Juergen Wehland | Method for producing stable, regeneratable antibody arrays |
| US20030077616A1 (en) * | 2001-04-19 | 2003-04-24 | Ciphergen Biosystems, Inc. | Biomolecule characterization using mass spectrometry and affinity tags |
| WO2002086081A2 (en) * | 2001-04-20 | 2002-10-31 | Carnegie Mellon University | Methods and systems for identifying proteins |
| WO2002088388A1 (en) * | 2001-04-26 | 2002-11-07 | Ruebben Albert | A method and a device for quantification of mutation loads |
| CA2446417A1 (en) * | 2001-05-03 | 2002-11-14 | Sigma Genosys, L.P. | Methods for assembling protein microarrays |
| US20050182242A1 (en) * | 2001-05-11 | 2005-08-18 | Michael Snyder | Global analysis of protein activities using proteome chips |
| US9157875B2 (en) * | 2001-05-16 | 2015-10-13 | Benjamin P. Warner | Drug development and manufacturing |
| US20080220441A1 (en) | 2001-05-16 | 2008-09-11 | Birnbaum Eva R | Advanced drug development and manufacturing |
| US7147687B2 (en) * | 2001-05-25 | 2006-12-12 | Nanosphere, Inc. | Non-alloying core shell nanoparticles |
| WO2002096262A2 (en) * | 2001-05-25 | 2002-12-05 | Northwestern University | Non-alloying core shell nanoparticles |
| US7262063B2 (en) | 2001-06-21 | 2007-08-28 | Bio Array Solutions, Ltd. | Directed assembly of functional heterostructures |
| US6844028B2 (en) * | 2001-06-26 | 2005-01-18 | Accelr8 Technology Corporation | Functional surface coating |
| AU2002345839A1 (en) * | 2001-06-26 | 2003-03-03 | Wisconsin Alumni Research Foundation | Gene expression alterations underlying the retardation of aging by caloric restriction in mammals |
| WO2003003014A1 (en) * | 2001-06-29 | 2003-01-09 | Veri-Q, Inc. | Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids |
| US20060019235A1 (en) * | 2001-07-02 | 2006-01-26 | The Board Of Trustees Of The Leland Stanford Junior University | Molecular and functional profiling using a cellular microarray |
| JP2005514617A (ja) * | 2001-07-02 | 2005-05-19 | ザ、ボード、オブ、トラスティーズ、オブ、ザ、リーランド、スタンフォード、ジュニア、ユニバーシティ | 細胞の表現型決定および操作のためのマイクロアレイ |
| US20030108949A1 (en) * | 2001-07-03 | 2003-06-12 | Gang Bao | Filtration-based microarray chip |
| WO2003004993A2 (en) * | 2001-07-06 | 2003-01-16 | Millipore Corporation | Satterned composite membrane and stenciling method for the manufacture thereof |
| EP1759210B1 (en) * | 2001-07-13 | 2008-12-31 | Nanosphere, Inc. | Method for preparing substrates having immobilized molecules and substrates |
| US7297553B2 (en) * | 2002-05-28 | 2007-11-20 | Nanosphere, Inc. | Method for attachment of silylated molecules to glass surfaces |
| US20030013208A1 (en) * | 2001-07-13 | 2003-01-16 | Milagen, Inc. | Information enhanced antibody arrays |
| WO2003006676A2 (en) * | 2001-07-13 | 2003-01-23 | Nanosphere, Inc. | Method for immobilizing molecules onto surfaces |
| JP3935487B2 (ja) * | 2001-07-16 | 2007-06-20 | フーベルト・ケスター | 捕獲化合物、その収集物、ならびにプロテオームおよび複合組成物の分析方法 |
| JP4108037B2 (ja) * | 2001-07-16 | 2008-06-25 | プロテイン, フォレスト, インコーポレイテッド | 生体分子の等電点によって生体分子を分析するためのバッファのアレイ |
| US7517496B2 (en) * | 2001-07-17 | 2009-04-14 | Bio-Rad Laboratories, Inc. | Latex based adsorbent chip |
| US6444318B1 (en) * | 2001-07-17 | 2002-09-03 | Surmodics, Inc. | Self assembling monolayer compositions |
| US7172804B2 (en) * | 2001-07-17 | 2007-02-06 | Northwestern University | Film-immobilized capture particles |
| WO2003008941A2 (en) * | 2001-07-17 | 2003-01-30 | Bioforce Nanosciences, Inc. | Combined molecular blinding detection through force microscopy and mass spectrometry |
| JP4264002B2 (ja) * | 2001-07-17 | 2009-05-13 | バイオ−ラド ラボラトリーズ インコーポレイテッド | ラテックスベース吸着チップ |
| US20030143612A1 (en) * | 2001-07-18 | 2003-07-31 | Pointilliste, Inc. | Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening |
| US6977138B2 (en) | 2001-07-24 | 2005-12-20 | Massachusetts Institute Of Technology | Reactive polymer coatings |
| EP1279963A1 (en) * | 2001-07-27 | 2003-01-29 | Université de Nantes | Protein-target screening method using near-infrared fluorescent dyes |
| EP1281966A3 (en) * | 2001-07-30 | 2003-06-18 | Fuji Photo Film Co., Ltd. | Method and apparatus for conducting a receptor-ligand reaction |
| WO2003011285A1 (en) * | 2001-08-01 | 2003-02-13 | Merck & Co., Inc. | BENZIMIDAZO[4,5-f]ISOQUINOLINONE DERIVATIVES |
| US7172905B2 (en) * | 2001-08-07 | 2007-02-06 | The University Of Chicago | Polypeptide immobilization |
| US20100104631A1 (en) * | 2001-08-13 | 2010-04-29 | Lipella Pharmaceuticals Inc. | Method of treatment for bladder dysfunction |
| US20030049626A1 (en) * | 2001-08-14 | 2003-03-13 | Milagen, Inc. | Antibody-based analysis of matrix protein arrays |
| US20030040129A1 (en) * | 2001-08-20 | 2003-02-27 | Shah Haresh P. | Binding assays using magnetically immobilized arrays |
| US6767731B2 (en) * | 2001-08-27 | 2004-07-27 | Intel Corporation | Electron induced fluorescent method for nucleic acid sequencing |
| CA2458844A1 (en) * | 2001-08-27 | 2003-03-06 | Surface Logix, Inc. | Immobilization of biological molecules onto surfaces coated with monolayers |
| US7075162B2 (en) * | 2001-08-30 | 2006-07-11 | Fluidigm Corporation | Electrostatic/electrostrictive actuation of elastomer structures using compliant electrodes |
| DK1432786T3 (da) | 2001-09-06 | 2009-10-26 | Rapid Micro Biosystems Inc | Hurtig detektion af replikerede celler |
| US20030068655A1 (en) * | 2001-09-12 | 2003-04-10 | Protiveris, Inc. | Microcantilever apparatus and methods for detection of enzymes |
| DE10145226A1 (de) * | 2001-09-13 | 2003-04-10 | Lifebits Ag | Herstellung von trägergebundenen Molekülen |
| DE10145700A1 (de) * | 2001-09-17 | 2003-04-10 | Infineon Technologies Ag | Biochip-Anordnung, Sensor-Anordnung und Verfahren zum Betreiben einer Biochip-Anordnung |
| JP2003099614A (ja) * | 2001-09-21 | 2003-04-04 | Daiwa Securities Group Inc | 保有口数内売却処理装置、保有口数内売却処理システム及びプログラム |
| US7042488B2 (en) | 2001-09-27 | 2006-05-09 | Fujinon Corporation | Electronic endoscope for highlighting blood vessel |
| US20030068446A1 (en) * | 2001-10-02 | 2003-04-10 | Northwestern University | Protein and peptide nanoarrays |
| US20030073104A1 (en) * | 2001-10-02 | 2003-04-17 | Belcher Angela M. | Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus |
| US7192629B2 (en) * | 2001-10-11 | 2007-03-20 | California Institute Of Technology | Devices utilizing self-assembled gel and method of manufacture |
| US8323903B2 (en) * | 2001-10-12 | 2012-12-04 | Life Technologies Corporation | Antibody complexes and methods for immunolabeling |
| US20050069962A1 (en) * | 2001-10-12 | 2005-03-31 | Archer Robert M | Antibody complexes and methods for immunolabeling |
| CA2741049C (en) | 2001-10-15 | 2019-02-05 | Bioarray Solutions, Ltd. | Multiplexed analysis of polymorphic loci by probe elongation-mediated detection |
| AU2002367935A1 (en) * | 2001-10-23 | 2003-12-22 | Sloan Kettering Institute For Cancer Research | Protein micro-arrays and multi-layered affinity interaction detection |
| US8440093B1 (en) | 2001-10-26 | 2013-05-14 | Fuidigm Corporation | Methods and devices for electronic and magnetic sensing of the contents of microfluidic flow channels |
| DE60228128D1 (de) | 2001-11-09 | 2008-09-18 | Nanosphere Inc | Biokonjugat-nanopartikelsonden |
| CA2467456A1 (en) * | 2001-11-19 | 2003-05-30 | Protometrix, Inc. | Method of using a non-antibody protein to detect and measure an analyte |
| DE60232688D1 (de) * | 2001-11-20 | 2009-07-30 | Univ Duke | Grenzflächen-biomaterialien |
| US7125669B2 (en) * | 2001-11-27 | 2006-10-24 | Compound Therapeutics, Inc. | Solid-phase immobilization of proteins and peptides |
| US6797393B2 (en) | 2001-11-30 | 2004-09-28 | Eastman Kodak Company | Method for making biochip substrate |
| US7691333B2 (en) | 2001-11-30 | 2010-04-06 | Fluidigm Corporation | Microfluidic device and methods of using same |
| JP4355210B2 (ja) | 2001-11-30 | 2009-10-28 | フルイディグム コーポレイション | 微小流体デバイスおよび微小流体デバイスの使用方法 |
| US7361310B1 (en) | 2001-11-30 | 2008-04-22 | Northwestern University | Direct write nanolithographic deposition of nucleic acids from nanoscopic tips |
| CA2469403C (en) * | 2001-12-05 | 2015-06-02 | Jonathan Mark Boutell | Protein arrays for allelic variants and uses thereof |
| US20050112616A1 (en) * | 2001-12-10 | 2005-05-26 | William Lee | Functionalized materials and libraries thereof |
| EP1319954A1 (en) * | 2001-12-12 | 2003-06-18 | Centre National de Genotypage | Methods for protein analysis using protein capture arrays |
| JP4382339B2 (ja) * | 2001-12-14 | 2009-12-09 | 富士フイルム株式会社 | 測定チップ |
| GB0130318D0 (en) * | 2001-12-19 | 2002-02-06 | Univ Leeds | Membrane |
| EP1456659B1 (en) * | 2001-12-21 | 2008-03-12 | GE Healthcare Bio-Sciences AB | Immobilization of binding agents |
| KR20030057219A (ko) * | 2001-12-28 | 2003-07-04 | 삼성에스디아이 주식회사 | 기질에 중간층을 형성시키는 화합물, 이를 포함하는중간층 형성용 조성물 및 이를 이용한 바이오칩 |
| KR100450202B1 (ko) * | 2002-01-07 | 2004-09-24 | 삼성에스디아이 주식회사 | 생체물질 고정용 관능기의 패턴 형성 방법 |
| US7056665B2 (en) * | 2002-01-16 | 2006-06-06 | Panomics, Inc. | Screening methods involving the detection of short-lived proteins |
| US20030134433A1 (en) * | 2002-01-16 | 2003-07-17 | Nanomix, Inc. | Electronic sensing of chemical and biological agents using functionalized nanostructures |
| US20070178477A1 (en) * | 2002-01-16 | 2007-08-02 | Nanomix, Inc. | Nanotube sensor devices for DNA detection |
| US20060228723A1 (en) * | 2002-01-16 | 2006-10-12 | Keith Bradley | System and method for electronic sensing of biomolecules |
| US20030157540A1 (en) * | 2002-01-16 | 2003-08-21 | Xianqiang Li | Methods for isolating and characterizing short-lived proteins and arrays derived therefrom |
| EP1474504A2 (en) * | 2002-01-24 | 2004-11-10 | Pointilliste, Inc. | Use of collections of binding sites for sample profiling and other applications |
| JP2003222589A (ja) * | 2002-01-31 | 2003-08-08 | Communication Research Laboratory | 二波長表面プラズモン共鳴分光装置 |
| SE0200269D0 (sv) * | 2002-01-31 | 2002-01-31 | Ellem Bioteknik Ab | Material for implantation |
| CA2474530A1 (en) * | 2002-02-07 | 2003-08-14 | Eastern Virginia Medical School Of The Medical College Of Hampton Roads | Diagnostic microarray and method of use thereof |
| US7501280B2 (en) * | 2002-03-01 | 2009-03-10 | National Institute Of Advanced Industrial Science And Technology | Immobilized cells and liposomes and method of immobilizing the same |
| US20050266455A1 (en) * | 2002-03-02 | 2005-12-01 | Sci Tec, Inc. | Method and microelectronic device for multi-site molecule detection |
| US6815078B2 (en) | 2002-03-06 | 2004-11-09 | Eastman Kodak Company | Substrate for protein microarray containing functionalized polymer |
| EP1565744A4 (en) * | 2002-03-07 | 2007-06-20 | Zephyr Proteomix Ltd | MICROARRAY'S CELLULOSE BINDING CHIMERIC PROTEINS AND METHOD OF USE THEREOF |
| EP1502102B1 (en) * | 2002-03-11 | 2009-01-14 | caprotec bioanalytics GmbH | Compounds and methods for analyzing the proteome |
| US6703216B2 (en) | 2002-03-14 | 2004-03-09 | The Regents Of The University Of California | Methods, compositions and apparatuses for detection of gamma-hydroxybutyric acid (GHB) |
| US20030228709A1 (en) * | 2002-03-25 | 2003-12-11 | Kozlowski Roland Zbignieiw | Arrays |
| CA2480728A1 (en) | 2002-04-01 | 2003-10-16 | Fluidigm Corporation | Microfluidic particle-analysis systems |
| US20030215858A1 (en) * | 2002-04-08 | 2003-11-20 | Baylor College Of Medicine | Enhanced gene expression system |
| US20040033546A1 (en) * | 2002-04-10 | 2004-02-19 | The Trustees Of Columbia University In The City Of New York | Novel microarrays and methods of use thereof |
| US20030194709A1 (en) * | 2002-04-10 | 2003-10-16 | Xing Yang | Hydrophobic zone device |
| US7687256B2 (en) * | 2002-04-11 | 2010-03-30 | Spire Corporation | Surface activated biochip |
| US20060014145A1 (en) * | 2002-04-26 | 2006-01-19 | Miller Brian S | Methods and articles for high throughput analysis of biomolecular interactions |
| US20040171034A1 (en) | 2002-05-03 | 2004-09-02 | Brian Agnew | Compositions and methods for detection and isolation of phosphorylated molecules |
| CN1665790A (zh) * | 2002-05-03 | 2005-09-07 | 莫莱丘莱尔探针公司 | 用于检测和分离磷酸化分子的组合物及方法 |
| US7445894B2 (en) * | 2002-05-03 | 2008-11-04 | Molecular Probes, Inc. | Compositions and methods for detection and isolation of phosphorylated molecules |
| US20030211488A1 (en) * | 2002-05-07 | 2003-11-13 | Northwestern University | Nanoparticle probs with Raman spectrocopic fingerprints for analyte detection |
| US20030211478A1 (en) * | 2002-05-08 | 2003-11-13 | Gentel Corporation | Transcription factor profiling on a solid surface |
| US20030208936A1 (en) * | 2002-05-09 | 2003-11-13 | Lee Charles Hee | Method for manufacturing embroidery decorated cards and envelopes |
| US7460960B2 (en) * | 2002-05-10 | 2008-12-02 | Epitome Biosystems, Inc. | Proteome epitope tags and methods of use thereof in protein modification analysis |
| US20060014212A1 (en) * | 2002-05-10 | 2006-01-19 | Epitome Biosystems, Inc. | Proteome epitope tags and methods of use thereof in protein modification analysis |
| AU2003302118A1 (en) * | 2002-05-10 | 2004-06-15 | Epitome Biosystems, Inc. | Unique recognition sequences and methods of use thereof in protein analysis |
| AU2003222676B2 (en) * | 2002-05-10 | 2009-04-23 | Anteo Technologies Pty Ltd | Generation of surface coating diversity |
| US7618788B2 (en) * | 2002-05-10 | 2009-11-17 | Millipore Corporation | Proteome epitope tags and methods of use thereof in protein modification analysis |
| EP1364710B1 (en) * | 2002-05-13 | 2009-10-07 | Becton, Dickinson and Company | Self-aliquoting sample storage plate |
| US8785179B2 (en) * | 2002-05-22 | 2014-07-22 | Texas Instruments Incorporated | Biosensor and method |
| US20050239193A1 (en) * | 2002-05-30 | 2005-10-27 | Bioforce Nanosciences, Inc. | Device and method of use for detection and characterization of microorganisms and microparticles |
| AU2003231947A1 (en) * | 2002-05-31 | 2003-12-19 | Aaron Diamond Aids Research Center | Defensins: use as antiviral agents |
| EP1369692A3 (en) * | 2002-06-04 | 2003-12-17 | Interuniversitaire Microelectronica Centrum vzw ( IMEC) | Sensor surface |
| EP1413886A1 (en) * | 2002-10-25 | 2004-04-28 | Interuniversitair Microelektronica Centrum ( Imec) | Sensor surface |
| US7135343B2 (en) * | 2002-06-17 | 2006-11-14 | Agilent Technologies, Inc. | Biomolecule resistant and their methods of use in assays |
| CA2490522A1 (en) * | 2002-06-20 | 2003-12-31 | Paul Stroobant | Improved methods for performing differential capture proteomics |
| US7948041B2 (en) | 2005-05-19 | 2011-05-24 | Nanomix, Inc. | Sensor having a thin-film inhibition layer |
| WO2004004647A2 (en) * | 2002-07-02 | 2004-01-15 | Nanosphere Inc. | Nanoparticle polyanion conjugates and methods of use thereof in detecting analytes |
| USH2223H1 (en) * | 2002-07-11 | 2008-09-02 | The United States Of America As Represented By The Secretary Of The Navy | Patterned, micrometer-sized antibody features |
| US20040009528A1 (en) * | 2002-07-11 | 2004-01-15 | Shyh-Yu Shaw | Protein chips |
| US20050008828A1 (en) * | 2002-07-25 | 2005-01-13 | Trustees Of Stevens Institute Of Technology | Patterned polymer microgel and method of forming same |
| JP4099822B2 (ja) * | 2002-07-26 | 2008-06-11 | セイコーエプソン株式会社 | ディスペンシング装置、ディスペンシング方法及び生体試料含有溶液吐出不良検出方法 |
| EP1572958A2 (en) * | 2002-07-29 | 2005-09-14 | MT Technologies, Inc. | Biomimetic membranes |
| US20050074898A1 (en) * | 2002-07-31 | 2005-04-07 | Caliper Technologies Corp. | High density reagent array preparation methods |
| US20040067597A1 (en) * | 2002-07-31 | 2004-04-08 | Caliper Technologies Corp. | High density reagent array preparation methods |
| WO2004013628A1 (en) * | 2002-08-02 | 2004-02-12 | Applera Corporation | Fluorescence polarization assay |
| AU2003257109A1 (en) * | 2002-08-05 | 2004-02-23 | Invitrogen Corporation | Compositions and methods for molecular biology |
| AU2003255253A1 (en) * | 2002-08-13 | 2004-02-25 | Discovery Partners International | Spotting pattern for placement of compounds in an array |
| GB2391867A (en) * | 2002-08-13 | 2004-02-18 | Smartbead Technologies Ltd | Analysis system using coded supports |
| AU2003259041A1 (en) * | 2002-08-15 | 2004-03-03 | Proteoplex, Inc. | Methods and apparatus for preparing and assaying biological samples to determine protein concentration |
| US7384742B2 (en) * | 2002-08-16 | 2008-06-10 | Decision Biomarkers, Inc. | Substrates for isolating reacting and microscopically analyzing materials |
| US20050233473A1 (en) * | 2002-08-16 | 2005-10-20 | Zyomyx, Inc. | Methods and reagents for surface functionalization |
| WO2004017042A2 (en) * | 2002-08-16 | 2004-02-26 | Zyomyx, Inc. | Methods and reagents for surface functionalization |
| WO2004020065A2 (en) * | 2002-08-28 | 2004-03-11 | Mt Technologies, Inc. | Microfluidic affinity system using polydimethylsiloxane and a surface modification process |
| CA2496777A1 (en) * | 2002-08-29 | 2004-05-06 | Bioscale, Inc. | Resonant sensor and sensing system |
| WO2004023142A1 (de) * | 2002-09-03 | 2004-03-18 | Zeptosens Ag | Analytische plattform und nachweisverfahren mit den in einer probe nachzuweisenden analyten als immobilisierten spezifischen bindungspartnern |
| US20040043508A1 (en) * | 2002-09-03 | 2004-03-04 | Frutos Anthony G. | Polymer-coated substrates for binding biological molecules |
| ATE520027T1 (de) * | 2002-09-03 | 2011-08-15 | Bayer Technology Services Gmbh | Analytische plattform und nachweisverfahren mit gegebenenfalls nach fraktionierung in einer probe nachzuweisenden analyten als immobilisierten spezifischen bindungspartnern |
| US7927822B2 (en) * | 2002-09-09 | 2011-04-19 | Sru Biosystems, Inc. | Methods for screening cells and antibodies |
| US7429492B2 (en) * | 2002-09-09 | 2008-09-30 | Sru Biosystems, Inc. | Multiwell plates with integrated biosensors and membranes |
| WO2004027422A1 (ja) * | 2002-09-17 | 2004-04-01 | Olympus Corporation | 基体上での複数成分間の反応によりターゲット物質を検出するために基体表面に液状反応成分を配置する方法および装置、並びにこの方法に使用するための物品 |
| JP2004105070A (ja) * | 2002-09-18 | 2004-04-08 | Inst Of Physical & Chemical Res | 無細胞タンパク質合成系を用いたリガンド結合タンパク質の製造方法及びその使用 |
| US20050064508A1 (en) | 2003-09-22 | 2005-03-24 | Semzyme | Peptide mediated synthesis of metallic and magnetic materials |
| AU2003267255A1 (en) * | 2002-09-20 | 2004-04-08 | Novus Molecular, Inc. | Methods and devices for active bioassay |
| AU2003282875A1 (en) | 2002-09-25 | 2004-04-19 | California Institute Of Technology | Microfluidic large scale integration |
| US8871446B2 (en) | 2002-10-02 | 2014-10-28 | California Institute Of Technology | Microfluidic nucleic acid analysis |
| US20040137526A1 (en) * | 2002-10-15 | 2004-07-15 | The Regents Of The University Of Michigan | Multidimensional protein separation system |
| WO2004035742A2 (en) * | 2002-10-15 | 2004-04-29 | Abmetrix, Inc. | Sets of digital antibodies directed against short epitopes, and methods using same |
| DE10249608A1 (de) * | 2002-10-18 | 2004-05-06 | Gkss-Forschungszentrum Geesthacht Gmbh | Vorrichtung und Verfahren zur Strukturanalyse und Detektion von komplexen Glykostrukturen |
| DE60322742D1 (de) * | 2002-10-25 | 2008-09-18 | Sense Proteomic Ltd | Enzymarray und enzymtest |
| US20040081969A1 (en) * | 2002-10-29 | 2004-04-29 | Ilsley Diane D. | Devices and methods for evaulating the quality of a sample for use in an array assay |
| EP1576126A3 (en) * | 2002-10-30 | 2005-10-26 | Pointilliste, Inc. | Systems for capture and analysis of biological particles and methods using the systems |
| US20030153013A1 (en) * | 2002-11-07 | 2003-08-14 | Ruo-Pan Huang | Antibody-based protein array system |
| AU2003280311A1 (en) * | 2002-11-08 | 2004-06-07 | University Of Copenhagen | Method of immobilising a protein to a zeolite |
| AU2003298655A1 (en) | 2002-11-15 | 2004-06-15 | Bioarray Solutions, Ltd. | Analysis, secure access to, and transmission of array images |
| US20040096914A1 (en) * | 2002-11-20 | 2004-05-20 | Ye Fang | Substrates with stable surface chemistry for biological membrane arrays and methods for fabricating thereof |
| WO2004053460A2 (en) * | 2002-12-11 | 2004-06-24 | New England Biolabs, Inc. | Carrier-ligand fusions and uses thereof |
| WO2004053105A2 (en) * | 2002-12-12 | 2004-06-24 | Nanosphere, Inc. | Direct snp detection with unamplified dna |
| EP1570043B1 (en) * | 2002-12-12 | 2013-07-24 | Novartis Vaccines and Diagnostics, Inc. | Device and method for in-line blood testing using biochips |
| EP1739185A1 (en) | 2002-12-18 | 2007-01-03 | Ciphergen Biosystems, Inc. | Serum biomarkers in lung cancer |
| US20040121339A1 (en) * | 2002-12-19 | 2004-06-24 | Jizhong Zhou | Special film-coated substrate for bio-microarray fabrication and use thereof |
| MXPA05006836A (es) * | 2002-12-22 | 2005-08-16 | Scripps Research Inst | Colecciones ordenadas de proteinas. |
| US7695723B2 (en) | 2002-12-31 | 2010-04-13 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
| US7785601B2 (en) | 2002-12-31 | 2010-08-31 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
| EP1583845A4 (en) * | 2003-01-02 | 2006-06-28 | Bioforce Nanosciences Inc | METHOD AND APPARATUS FOR MOLECULAR ANALYSIS IN SMALL SAMPLE VOLUMES |
| KR100523212B1 (ko) * | 2003-01-04 | 2005-10-24 | 한국과학기술원 | 반응 단백질과 그의 기질 펩타이드간의 반응분석을 위한단백질 칩 |
| US7736909B2 (en) * | 2003-01-09 | 2010-06-15 | Board Of Regents, The University Of Texas System | Methods and compositions comprising capture agents |
| EP1582589B1 (en) * | 2003-01-10 | 2010-03-24 | Protein Crystal Co., Ltd. | Protein complex, process for producing the same and use thereof |
| US7422865B2 (en) * | 2003-01-13 | 2008-09-09 | Agilent Technologies, Inc. | Method of identifying peptides in a proteomic sample |
| US20040137158A1 (en) * | 2003-01-15 | 2004-07-15 | Kools Jacques Constant Stefan | Method for preparing a noble metal surface |
| ATE489629T1 (de) * | 2003-01-16 | 2010-12-15 | Caprotec Bioanalytics Gmbh | Verfahren zur identifizierung von auf arzneimittel nicht-zielgerichteten proteinen |
| KR100994566B1 (ko) * | 2003-01-20 | 2010-11-15 | 삼성전자주식회사 | 고정화 영역을 갖는 포토레지스트 막을 포함하는 어레이장치 및 이를 이용한 표적 물질 검출방법 |
| WO2004071641A2 (en) * | 2003-02-10 | 2004-08-26 | Pointilliste, Inc. | Self-assembling arrays and uses thereof |
| US20050008851A1 (en) * | 2003-02-18 | 2005-01-13 | Fuji Photo Film Co., Ltd. | Biosensor |
| US20070287015A1 (en) * | 2003-02-25 | 2007-12-13 | Yeda Research And Development Co. Ltd. | Nanoscopic Structure and Devices Using the Same |
| WO2004075855A2 (en) * | 2003-02-26 | 2004-09-10 | Biomed Solutions, Llc | Process for in vivo treatment of specific biological targets in bodily fluid |
| EP1597399A2 (en) * | 2003-02-27 | 2005-11-23 | Nanosphere, Inc. | Label-free gene expression profiling with universal nanoparticle probes in microarray assay format |
| CN1514243A (zh) * | 2003-04-30 | 2004-07-21 | 成都夸常科技有限公司 | 对目标物进行定性和/或定量分析的方法、装置和标记物及检测试剂盒 |
| EP2390352A1 (en) | 2003-03-18 | 2011-11-30 | Quantum Genetics Ireland Limited | Systems and methods for improving protein and milk production of dairy herds |
| US20040185445A1 (en) * | 2003-03-19 | 2004-09-23 | Ye Fang | Universal readout for target identification using biological microarrays |
| US7191068B2 (en) * | 2003-03-25 | 2007-03-13 | Proteogenix, Inc. | Proteomic analysis of biological fluids |
| US8068990B2 (en) * | 2003-03-25 | 2011-11-29 | Hologic, Inc. | Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids |
| US20040248287A1 (en) * | 2003-03-28 | 2004-12-09 | Qianjin Hu | Multi-array systems and methods of use thereof |
| US20040197841A1 (en) * | 2003-04-02 | 2004-10-07 | Apffel James Alexander | Methods and reagents for multiplexed analyses |
| US8828663B2 (en) | 2005-03-18 | 2014-09-09 | Fluidigm Corporation | Thermal reaction device and method for using the same |
| US7604965B2 (en) | 2003-04-03 | 2009-10-20 | Fluidigm Corporation | Thermal reaction device and method for using the same |
| US20050145496A1 (en) | 2003-04-03 | 2005-07-07 | Federico Goodsaid | Thermal reaction device and method for using the same |
| EP2340890B1 (en) | 2003-04-03 | 2016-10-19 | Fluidigm Corporation | Method of performimg digital PCR |
| US7476363B2 (en) | 2003-04-03 | 2009-01-13 | Fluidigm Corporation | Microfluidic devices and methods of using same |
| US20040248205A1 (en) * | 2003-04-16 | 2004-12-09 | Stern Lawrence J. | Major histocompatibility complex (MHC)-peptide arrays |
| WO2004094460A2 (en) | 2003-04-17 | 2004-11-04 | Ciphergen Biosystems, Inc. | Polypeptides related to natriuretic peptides and methods of their identification and use |
| WO2004094989A2 (en) * | 2003-04-22 | 2004-11-04 | Ciphergen Biosystems, Inc. | Methods of host cell protein analysis |
| WO2004097368A2 (en) * | 2003-04-28 | 2004-11-11 | Ciphergen Biosystems, Inc. | Improved immunoassays |
| US7425700B2 (en) | 2003-05-22 | 2008-09-16 | Stults John T | Systems and methods for discovery and analysis of markers |
| KR100547015B1 (ko) * | 2003-05-23 | 2006-01-26 | 주식회사 올메디쿠스 | 일정한 크기 이상의 분석물질을 정량 분석하기 위한바이오센서 및 그 제조방법 |
| US20050250094A1 (en) * | 2003-05-30 | 2005-11-10 | Nanosphere, Inc. | Method for detecting analytes based on evanescent illumination and scatter-based detection of nanoparticle probe complexes |
| US20040248323A1 (en) * | 2003-06-09 | 2004-12-09 | Protometrix, Inc. | Methods for conducting assays for enzyme activity on protein microarrays |
| EP1634947A4 (en) * | 2003-06-10 | 2007-10-03 | Shimadzu Corp | EXTRACT FROM A CULTURED MAMMALIAN CELL, PROCESS FOR THEIR PREPARATION AND METHOD FOR CELL-FREE PROTEIN SYNTHESIS USING THE EXTRACT |
| WO2004113872A2 (en) * | 2003-06-24 | 2004-12-29 | The Trustees Of Columbia University In The City Of New York | Covalent methods for immobilization of thiolated biomolecules on siliceous and metallic surfaces |
| US20040265921A1 (en) * | 2003-06-30 | 2004-12-30 | National University Of Singapore | Intein-mediated attachment of ligands to proteins for immobilization onto a support |
| US20050272105A1 (en) * | 2003-07-10 | 2005-12-08 | Kalle Levon | Bacterial biosensors |
| US7794947B2 (en) * | 2003-07-10 | 2010-09-14 | Institute For Systems Biology | Affinity capture of peptides by microarray and related methods |
| WO2005010494A2 (en) * | 2003-07-21 | 2005-02-03 | Jie Wu | Multiplexed analyte detection |
| US20060014003A1 (en) * | 2003-07-24 | 2006-01-19 | Libera Matthew R | Functional nano-scale gels |
| CN1878866B (zh) | 2003-07-25 | 2012-08-01 | 安比恩股份有限公司 | 用于从固定的样品中制备rna的方法和组合物 |
| US20050059024A1 (en) | 2003-07-25 | 2005-03-17 | Ambion, Inc. | Methods and compositions for isolating small RNA molecules |
| US7745023B2 (en) * | 2003-08-08 | 2010-06-29 | Regents Of The University Of Minnesota | Structured material for the production of hydrogen |
| WO2005014795A2 (en) | 2003-08-08 | 2005-02-17 | Genenews Inc. | Osteoarthritis biomarkers and uses thereof |
| US7413712B2 (en) | 2003-08-11 | 2008-08-19 | California Institute Of Technology | Microfluidic rotary flow reactor matrix |
| US7223609B2 (en) * | 2003-08-14 | 2007-05-29 | Agilent Technologies, Inc. | Arrays for multiplexed surface plasmon resonance detection of biological molecules |
| CA2536062A1 (en) * | 2003-08-18 | 2005-03-03 | Tethys Bioscience, Inc. | Methods for reducing complexity of a sample using small epitope antibodies |
| WO2005022156A1 (ja) * | 2003-08-29 | 2005-03-10 | Reverse Proteomics Research Institute Co., Ltd. | タンパク質の固定化方法 |
| EP1668364A4 (en) | 2003-09-03 | 2012-06-06 | Zyomix Inc | ION DETECTION USING COLUMN CHIP |
| US20050176026A1 (en) * | 2003-09-05 | 2005-08-11 | Franck Carl P. | Liquid mixing reactor for biochemical assays |
| US20050053949A1 (en) * | 2003-09-08 | 2005-03-10 | Silin Vitalii Ivanovich | Biochip for proteomics applications |
| US20050059083A1 (en) * | 2003-09-15 | 2005-03-17 | Becton Dickinson And Company | High throughput method to identify ligands for cell attachment |
| US7927796B2 (en) | 2003-09-18 | 2011-04-19 | Bioarray Solutions, Ltd. | Number coding for identification of subtypes of coded types of solid phase carriers |
| KR100518953B1 (ko) * | 2003-09-19 | 2005-10-12 | 주식회사 제노포커스 | 포자 외막단백질을 이용한 목적단백질의 표면발현 방법 |
| US7998435B2 (en) | 2003-09-19 | 2011-08-16 | Life Technologies Corporation | High density plate filler |
| US9492820B2 (en) | 2003-09-19 | 2016-11-15 | Applied Biosystems, Llc | High density plate filler |
| US7407630B2 (en) | 2003-09-19 | 2008-08-05 | Applera Corporation | High density plate filler |
| US7695688B2 (en) * | 2003-09-19 | 2010-04-13 | Applied Biosystems, Llc | High density plate filler |
| US8277760B2 (en) | 2003-09-19 | 2012-10-02 | Applied Biosystems, Llc | High density plate filler |
| US8298780B2 (en) * | 2003-09-22 | 2012-10-30 | X-Body, Inc. | Methods of detection of changes in cells |
| ES2375962T3 (es) | 2003-09-22 | 2012-03-07 | Bioarray Solutions Ltd | Polielectrolito inmovilizado en superficie con múltiples grupos funcionales capaces de unirse covalentemente a biomoléculas. |
| US20050069949A1 (en) * | 2003-09-30 | 2005-03-31 | International Business Machines Corporation | Microfabricated Fluidic Structures |
| JP2007507721A (ja) * | 2003-09-30 | 2007-03-29 | クロンバ,インコーポレーテッド | クロマトグラフィー及びサンプル調製のためのマルチキャピラリーカラム |
| US20050069462A1 (en) * | 2003-09-30 | 2005-03-31 | International Business Machines Corporation | Microfluidics Packaging |
| US20070017870A1 (en) | 2003-09-30 | 2007-01-25 | Belov Yuri P | Multicapillary device for sample preparation |
| US20050079507A1 (en) * | 2003-10-09 | 2005-04-14 | Ye Fang | Target evaluation using biological membrane arrays |
| WO2005047851A2 (en) * | 2003-10-15 | 2005-05-26 | The Trustees Of Columbia University In The City Of New York | Device for measuring nanometer level pattern-dependent binding reactions |
| US20050084981A1 (en) * | 2003-10-16 | 2005-04-21 | Magdalena Ostrowski | Method of depositing a bioactive material on a substrate |
| US20050112650A1 (en) * | 2003-10-20 | 2005-05-26 | Ciphergen Biosystems, Inc. | Reactive polyurethane-based polymers |
| WO2005040800A1 (es) * | 2003-10-23 | 2005-05-06 | Consejo Superior De Investigaciones Científicas | Procedimiento de fabricación y uso de un nuevo array de proteínas, dicho array de proteínas y sus aplicaciones |
| JP2006514299A (ja) * | 2003-10-27 | 2006-04-27 | センス プロテオミック リミテッド | 酵素アレイ及びアッセイ |
| NZ547492A (en) | 2003-10-28 | 2009-12-24 | Bioarray Solutions Ltd | Optimization of gene expression analysis using immobilized capture probes of different lengths and densities |
| NZ547495A (en) | 2003-10-29 | 2008-05-30 | Bioarray Solutions Ltd | Multiplexed nucleic acid analysis by fragmentation of double-stranded DNA |
| US20050095648A1 (en) * | 2003-10-30 | 2005-05-05 | Mario Geysen | Method for designing linear epitopes and algorithm therefor and polypeptide epitopes |
| EP1680679A2 (en) * | 2003-11-06 | 2006-07-19 | SRU Biosystems Inc. | High-density amine-functionalized surface |
| JP4796967B2 (ja) | 2003-11-07 | 2011-10-19 | ヴァーミリオン インコーポレイテッド | アルツハイマー病のためのバイオマーカー |
| US20060007515A1 (en) * | 2003-11-13 | 2006-01-12 | Dmitri Simonian | Surface lubrication in microstructures |
| US7153896B2 (en) | 2003-11-14 | 2006-12-26 | Eastman Kodak Company | Element for protein microarrays |
| US7332355B2 (en) | 2003-11-18 | 2008-02-19 | California Institute Of Technology | Method and compositions for the detection of protein glycosylation |
| EP2264191A1 (en) | 2003-11-21 | 2010-12-22 | ANP Technologies, Inc. | Asymmetrically branched polymer conjugates and microarray assays |
| US20090246889A1 (en) * | 2003-11-22 | 2009-10-01 | Samsung Electronics Co., Ltd. | Substrate having oxide layer, method for detecting target material using the substrate, and optical sensor including the substrate |
| KR100580631B1 (ko) * | 2003-11-22 | 2006-05-16 | 삼성전자주식회사 | 산화막을 갖는 기판, 그를 이용한 표적 물질 검출 방법 및광학적 센서 |
| US20050109622A1 (en) * | 2003-11-26 | 2005-05-26 | Peter Peumans | Method for controlling electrodeposition of an entity and devices incorporating the immobilized entity |
| CA2547861A1 (en) | 2003-12-05 | 2005-06-23 | Ciphergen Biosystems, Inc. | Serum biomarkers for chagas disease |
| EP1700244A4 (en) * | 2003-12-12 | 2009-07-08 | Bio Layer Pty Ltd | PROCESS FOR THE PREPARATION OF SURFACES |
| JP2007514173A (ja) | 2003-12-15 | 2007-05-31 | ユニバーシティ オブ ペンシルベニア | Maldi質量分析に向けたターゲットプレート上で反応を行うための方法および装置 |
| US20050170445A1 (en) * | 2004-01-07 | 2005-08-04 | Duke University | Methods of establishing profiles for use in evaluating wound healing and biocompatibility of implant materials and microarrays useful therefor |
| WO2005067980A2 (en) * | 2004-01-12 | 2005-07-28 | Pointilliste, Inc. | Design of therapeutics and therapeutics |
| US20050208597A1 (en) * | 2004-01-26 | 2005-09-22 | The Board Of Trustees Of The Leland Stanford Junior University | Microarray analysis of post-translational modifications |
| JP2005204609A (ja) * | 2004-01-26 | 2005-08-04 | Canon Inc | 有機物固定化用キット、有機物固定化構造体及びその製造方法 |
| EP1562046A1 (de) * | 2004-02-03 | 2005-08-10 | B.R.A.H.M.S Aktiengesellschaft | Diagnose von Sepsis durch selektive Bestimmung der Konzentration der Cu/Zn Superoxiddismutase (Cu/Zn SOD) in Patientenproben |
| CA2556911C (en) | 2004-02-19 | 2013-07-30 | The Governors Of The University Of Alberta | Leptin promoter polymorphisms and uses thereof |
| JP2005269902A (ja) * | 2004-03-22 | 2005-10-06 | Seiko Epson Corp | 固相表面に細胞を固定化する方法 |
| US7276283B2 (en) * | 2004-03-24 | 2007-10-02 | Wisconsin Alumni Research Foundation | Plasma-enhanced functionalization of carbon-containing substrates |
| US7723126B2 (en) * | 2004-03-24 | 2010-05-25 | Wisconsin Alumni Research Foundation | Plasma-enhanced functionalization of inorganic oxide surfaces |
| CN100357738C (zh) * | 2004-03-26 | 2007-12-26 | 博奥生物有限公司 | 一种检测小分子化合物的方法 |
| US7371331B2 (en) * | 2004-04-01 | 2008-05-13 | Valerie J Marty | Method of creating a patterned monolayer on a surface |
| JP4451193B2 (ja) * | 2004-04-12 | 2010-04-14 | 大日本印刷株式会社 | パターン形成体の製造方法 |
| WO2005108615A2 (en) * | 2004-04-14 | 2005-11-17 | President And Fellows Of Harvard College | Nucleic-acid programmable protein arrays |
| US7396654B2 (en) | 2004-04-15 | 2008-07-08 | University Of Florida Research Foundation, Inc. | Neural proteins as biomarkers for traumatic brain injury |
| EP1743031A4 (en) | 2004-04-26 | 2008-05-28 | Childrens Medical Center | BLOOD PLATE BIOMARKERS FOR THE DETECTION OF ILLNESSES |
| US20080304068A1 (en) * | 2004-04-28 | 2008-12-11 | Tsuneo Urisu | Biochip Production Method, Biochip, Biochip Analysis Apparatus, and Biochip Analysis Method |
| EP2527447A1 (en) | 2004-06-03 | 2012-11-28 | Athlomics Pty Ltd | Agents and methods for diagnosing stress |
| US20060251795A1 (en) * | 2005-05-05 | 2006-11-09 | Boris Kobrin | Controlled vapor deposition of biocompatible coatings for medical devices |
| DE102004031258A1 (de) * | 2004-06-29 | 2006-02-09 | Jennissen, Herbert P., Prof. Dr. | Proteinhybride mit polyhydroxyaromatischen Aminosäure-Epitopen |
| AU2005259833B2 (en) | 2004-07-02 | 2011-09-22 | Anteo Technologies Pty Ltd | Use of metal complexes |
| US20060009623A1 (en) * | 2004-07-06 | 2006-01-12 | National University Of Singapore | C-terminal attachment of ligands to proteins for immobilization onto a support |
| US20060014155A1 (en) * | 2004-07-16 | 2006-01-19 | Wisconsin Alumni Research Foundation | Methods for the production of sensor arrays using electrically addressable electrodes |
| WO2006007664A1 (en) * | 2004-07-22 | 2006-01-26 | Genomics Research Partners Pty Ltd | Agents and methods for diagnosing osteoarthritis |
| EP1789437A4 (en) * | 2004-07-30 | 2008-11-05 | Sinai School Medicine | INHIBITORS OF NPC1L1 AND NPC1L1 AND METHODS OF USE THEREOF |
| US7848889B2 (en) | 2004-08-02 | 2010-12-07 | Bioarray Solutions, Ltd. | Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification |
| AU2005269227A1 (en) * | 2004-08-04 | 2006-02-09 | Axela Inc. | Patterned surfaces with chemical crosslinkers for use in diffraction-based sensing |
| US20060040377A1 (en) * | 2004-08-17 | 2006-02-23 | Biocept, Inc. | Protein microarrays |
| US20130040840A1 (en) * | 2004-09-02 | 2013-02-14 | Bioarray Solutions, Ltd. | Nucleic acid amplification with integrated multiplex detection |
| US20060051348A1 (en) | 2004-09-09 | 2006-03-09 | Jorn Gorlach | Method of producing a plurality of isolated antibodies to a plurality of cognate antigens |
| US20060052948A1 (en) * | 2004-09-09 | 2006-03-09 | Jorn Gorlach | Method of identifying drugs, targeting moieties or diagnostics |
| CA2591926A1 (en) * | 2004-09-20 | 2006-03-30 | Proteogenix, Inc. | Diagnosis of fetal aneuploidy |
| ITVR20040149A1 (it) * | 2004-09-22 | 2004-12-22 | Sanitaria Scaligera Spa | Sistema di monitoraggio rapido del gruppo sanguigno e per la rivelazione di reazioni immunoematologiche |
| US7592139B2 (en) | 2004-09-24 | 2009-09-22 | Sandia National Laboratories | High temperature flow-through device for rapid solubilization and analysis |
| JP2006095452A (ja) * | 2004-09-30 | 2006-04-13 | Fuji Photo Film Co Ltd | スピンコート製膜法 |
| WO2006041392A1 (en) * | 2004-10-13 | 2006-04-20 | Biacore Ab | Preparation and use of a reactive solid support surface |
| SE0402476D0 (sv) * | 2004-10-13 | 2004-10-13 | Biacore Ab | Preparation and use of a reactive solid support surface |
| WO2006047417A2 (en) | 2004-10-21 | 2006-05-04 | University Of Florida Research Foundation, Inc. | Detection of cannabinoid receptor biomarkers and uses thereof |
| US20110077164A1 (en) * | 2004-10-23 | 2011-03-31 | Andras Guttman | Expression profiling platform technology |
| WO2006043179A1 (en) * | 2004-10-23 | 2006-04-27 | Biosystems International Sas | Expression profiling platform technology |
| WO2006049498A1 (en) * | 2004-11-05 | 2006-05-11 | Modiquest B.V. | Means and methods for isolating and/or identifying a target molecule |
| US20060246467A1 (en) * | 2004-11-15 | 2006-11-02 | California Institute Of Technology | Biomarker sensors and method for multi-color imaging and processing of single-molecule life signatures |
| US20060223195A1 (en) * | 2004-11-16 | 2006-10-05 | Meyer Grant D | Stress based removal of nonspecific binding from surfaces |
| EP1812714B1 (de) * | 2004-11-19 | 2008-03-26 | ebm-papst St. Georgen GmbH & Co. KG | Anordnung mit einem luefter und einer pumpe |
| US7745143B2 (en) * | 2004-11-19 | 2010-06-29 | Plexera, Llc | Plasmon resonance biosensor and method |
| EP1816473A4 (en) * | 2004-11-24 | 2007-10-31 | Inst Molekulyarnoi Biolog Im V | PROCESS FOR THE QUANTITATIVE DETECTION OF BIOLOGICAL TOXINS |
| EP1817425B1 (en) * | 2004-11-29 | 2013-03-06 | Centre National de la Recherche Scientifique | Trichloro silyl alkyl isocyanate molecule and surface modified mineral substrate |
| US7838307B2 (en) * | 2004-12-08 | 2010-11-23 | Lyotropic Therapeutics, Inc. | Compositions for binding to assay substrata and methods of using |
| WO2006071132A1 (fr) * | 2004-12-28 | 2006-07-06 | Institut Molekulyarnoi Biologii Im. V.A. Engelgardta Rossiiskoi Akademii Nauk | Micropuce a adn destinee au dosage immunologique parallele multiple de composes, et procedes de dosage immunologique faisant appel a ladite micropuce |
| JP2008527351A (ja) * | 2005-01-06 | 2008-07-24 | イースタン バージニア メディカル スクール | 前立腺癌のバイオマーカーとしてのアポリポタンパク質a−iiアイソフォーム |
| AU2006207954A1 (en) | 2005-01-28 | 2006-08-03 | Childrens Medical Center Corporation | Methods for diagnosis and prognosis of epithelial cancers |
| US7396689B2 (en) * | 2005-02-04 | 2008-07-08 | Decision Biomarkers Incorporated | Method of adjusting the working range of a multi-analyte assay |
| EP2520669A3 (en) | 2005-02-07 | 2013-02-27 | GeneNews Inc. | Mild osteoathritis biomarkers and uses thereof |
| US20060240478A1 (en) * | 2005-02-23 | 2006-10-26 | Fuji Photo Film Co., Ltd. | Biosensor |
| JP2006335912A (ja) * | 2005-06-03 | 2006-12-14 | Fujifilm Holdings Corp | 生理活性物質固定化剤 |
| US20060234265A1 (en) * | 2005-03-21 | 2006-10-19 | Jim Richey | Microarrays having multi-functional, compartmentalized analysis areas and methods of use |
| JP4435709B2 (ja) * | 2005-03-22 | 2010-03-24 | 富士フイルム株式会社 | バイオセンサー |
| EP1871913A2 (en) | 2005-03-25 | 2008-01-02 | Ambion, Inc. | Methods and compositions for depleting abundant rna transcripts |
| WO2006107846A2 (en) | 2005-04-01 | 2006-10-12 | University Of Florida Research Foundation, Inc. | Biomakers of liver injury |
| US8048638B2 (en) | 2005-04-01 | 2011-11-01 | University Of Florida Research Foundation, Inc. | Biomarkers of liver injury |
| WO2006113785A2 (en) * | 2005-04-18 | 2006-10-26 | Brigham Young University | Laser modification and functionalization of substrates |
| CN101208599B (zh) * | 2005-04-26 | 2014-12-10 | 拜耳知识产权有限责任公司 | 用于涂覆通过亲和力-测定法用于被分析物检测的底物基质的新的设备和方法 |
| US7300631B2 (en) | 2005-05-02 | 2007-11-27 | Bioscale, Inc. | Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles |
| EP2208998A3 (en) | 2005-05-02 | 2011-03-16 | ANP Technologies, Inc. | Polymer conjugate enhanced bioassays |
| US7749445B2 (en) * | 2005-05-02 | 2010-07-06 | Bioscale, Inc. | Method and apparatus for analyzing bioprocess fluids |
| US7648844B2 (en) * | 2005-05-02 | 2010-01-19 | Bioscale, Inc. | Method and apparatus for detection of analyte using an acoustic device |
| US7611908B2 (en) * | 2005-05-02 | 2009-11-03 | Bioscale, Inc. | Method and apparatus for therapeutic drug monitoring using an acoustic device |
| WO2006124644A2 (en) * | 2005-05-12 | 2006-11-23 | Board Of Regents, The University Of Texas System | Protein and antibody profiling using small molecule microarrays |
| US8486629B2 (en) | 2005-06-01 | 2013-07-16 | Bioarray Solutions, Ltd. | Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation |
| US20070021433A1 (en) | 2005-06-03 | 2007-01-25 | Jian-Qiang Fan | Pharmacological chaperones for treating obesity |
| EP3130350A1 (en) | 2005-06-08 | 2017-02-15 | Dana-Farber Cancer Institute, Inc. | Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1)pathway |
| WO2006138479A2 (en) * | 2005-06-15 | 2006-12-28 | Arizona Board Of Regents For And On Behalf Of Arizona State University | Microstructure and microdomain microarrays, methods of making and using thereof |
| WO2007002567A2 (en) * | 2005-06-23 | 2007-01-04 | Nanosphere, Inc. | Selective isolation and concentration of nucleic acids from complex samples |
| EP1904852A2 (en) | 2005-06-24 | 2008-04-02 | Ciphergen Biosystems, Inc. | Biomarkers for ovarian cancer: beta-2 microglobulin |
| CN101501215A (zh) | 2005-07-07 | 2009-08-05 | 阿什洛米克斯控股有限公司 | 用于诊断内毒素血症的多核苷酸标记基因及它们的表达 |
| EP2360473A1 (en) | 2005-08-22 | 2011-08-24 | Cornell Research Foundation | Compositions and methods for analyzing protein interactions |
| US7464580B2 (en) * | 2005-09-26 | 2008-12-16 | Oakland University | Ionic liquid high temperature gas sensors |
| WO2007038478A2 (en) | 2005-09-26 | 2007-04-05 | Rapid Micro Biosystems, Inc | Cassette containing growth medium |
| US20070202515A1 (en) * | 2005-10-12 | 2007-08-30 | Pathologica, Llc. | Promac signature application |
| US20070141627A1 (en) * | 2005-10-19 | 2007-06-21 | Behrens Timothy W | Systemic Lupus Erythematosus |
| US8239136B2 (en) | 2005-10-21 | 2012-08-07 | Genenews Inc. | Method, computer system and computer-readable medium for determining a probability of colorectal cancer in a test subject |
| US7955837B2 (en) | 2005-10-29 | 2011-06-07 | Bayer Technology Services Gmbh | Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof |
| FR2893130B1 (fr) * | 2005-11-08 | 2008-05-02 | Thales Sa | Dispositif d'imagerie pour biopuce, et biopuce associee |
| EP1951710A4 (en) | 2005-11-09 | 2010-08-25 | Univ Columbia | PHOTOCHEMICAL PROCESSES AND PHOTOACTIVE COMPOSITIONS FOR MODIFYING SURFACES |
| US8007995B2 (en) * | 2005-11-10 | 2011-08-30 | Bristol-Myers Squibb Company | Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in breast cancers |
| US7889347B2 (en) * | 2005-11-21 | 2011-02-15 | Plexera Llc | Surface plasmon resonance spectrometer with an actuator driven angle scanning mechanism |
| US7463358B2 (en) * | 2005-12-06 | 2008-12-09 | Lumera Corporation | Highly stable surface plasmon resonance plates, microarrays, and methods |
| WO2007070809A2 (en) * | 2005-12-12 | 2007-06-21 | Mcgill University | Biomarkers for babesia |
| US8841255B2 (en) | 2005-12-20 | 2014-09-23 | Duke University | Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides |
| ES2779992T3 (es) | 2005-12-20 | 2020-08-21 | Univ Duke | Métodos y composiciones para suministrar agentes activos con propiedades farmacológicas potenciadas |
| US20130172274A1 (en) | 2005-12-20 | 2013-07-04 | Duke University | Methods and compositions for delivering active agents with enhanced pharmacological properties |
| JP2007171003A (ja) * | 2005-12-22 | 2007-07-05 | Fujifilm Corp | 質量分析用基板並びに分析方法および装置 |
| US7781203B2 (en) * | 2005-12-29 | 2010-08-24 | Corning Incorporated | Supports for assaying analytes and methods of making and using thereof |
| US20090306342A1 (en) * | 2005-12-30 | 2009-12-10 | Bio-Layer Pty Limited | Binding of molecules |
| SG176453A1 (en) * | 2006-01-03 | 2011-12-29 | Harvard College | Small molecule printing |
| US7709227B2 (en) * | 2006-01-04 | 2010-05-04 | Phasebio Pharmaceuticals, Inc. | Multimeric ELP fusion constructs |
| US7648834B2 (en) * | 2006-01-17 | 2010-01-19 | Moore Wayne E | Plasmon fluorescence augmentation for chemical and biological testing apparatus |
| WO2007084962A2 (en) * | 2006-01-18 | 2007-07-26 | The Regents Of The University Of California | A fluid membrane-based ligand display system for live cell assays and disease diagnosis applications |
| CA2640614A1 (en) * | 2006-01-27 | 2007-08-09 | Eastern Virginia Medical School | Proteomic fingerprinting of human ivf-derived embryos: identification of biomarkers of developmental potential |
| JP4833679B2 (ja) * | 2006-01-31 | 2011-12-07 | 富士通株式会社 | 密度が調整された分子膜の製造方法及び製造装置 |
| US8008067B2 (en) * | 2006-02-13 | 2011-08-30 | University Of Maryland, Baltimore County | Microwave trigger metal-enhanced chemiluminescence (MT MEC) and spatial and temporal control of same |
| CA2642833A1 (en) | 2006-02-17 | 2007-08-30 | Children's Medical Center Corporation | Free ngal as a biomarker for cancer |
| US20070207504A1 (en) * | 2006-03-06 | 2007-09-06 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Proteomic methods for the identification of differentiated adipose cells and adipose derived adult stem cells |
| US8097425B2 (en) * | 2006-03-10 | 2012-01-17 | Tethys Bioscience, Inc. | Multiplex protein fractionation |
| WO2007106466A2 (en) | 2006-03-11 | 2007-09-20 | The Board Of Trustees Of The Leland Stanford Junior University | Beta-2 microglobulin as a biomarker for peripheral artery disease |
| US7855057B2 (en) * | 2006-03-23 | 2010-12-21 | Millipore Corporation | Protein splice variant/isoform discrimination and quantitative measurements thereof |
| US7909928B2 (en) | 2006-03-24 | 2011-03-22 | The Regents Of The University Of Michigan | Reactive coatings for regioselective surface modification |
| EP2351610A3 (en) | 2006-03-28 | 2011-10-12 | Inanovate, Inc. | Nano-particle biochip substrates |
| US7886577B2 (en) | 2006-03-30 | 2011-02-15 | Oakland University | Devices with surface bound ionic liquids and method of use thereof |
| US8375768B2 (en) * | 2006-03-30 | 2013-02-19 | Oakland University | Ionic liquid thin layer sensor for electrochemical and/or piezoelectric measurements |
| US20080026386A1 (en) * | 2006-03-31 | 2008-01-31 | Behrens Timothy W | Irf-5 haplotypes in systemic lupus erythematosus |
| US20080003694A1 (en) * | 2006-04-18 | 2008-01-03 | Swanson Basil I | Robust, self-assembled, biocompatible films |
| US7923054B2 (en) | 2006-04-19 | 2011-04-12 | Gore Enterprise Holdings, Inc. | Functional porous substrates for attaching biomolecules |
| US20100216657A1 (en) * | 2006-05-16 | 2010-08-26 | Arcxis Biotechnologies, Inc. | Pcr-free sample preparation and detection systems for high speed biologic analysis and identification |
| CA2653792A1 (en) * | 2006-05-31 | 2007-12-06 | The Johns Hopkins University | Ablation based laser machining of biomolecule patterns on substrates |
| US7947148B2 (en) | 2006-06-01 | 2011-05-24 | The Regents Of The University Of Michigan | Dry adhesion bonding |
| EP2041556A1 (en) * | 2006-06-28 | 2009-04-01 | RGB Technologies AB | A sensor kit and a system for detecting an analyte in a test environment |
| US8178316B2 (en) * | 2006-06-29 | 2012-05-15 | President And Fellows Of Harvard College | Evaluating proteins |
| FR2903590B1 (fr) * | 2006-07-13 | 2013-05-10 | Commissariat Energie Atomique | Dispositif de prelevement cellulaire par contact |
| US20100003189A1 (en) | 2006-07-14 | 2010-01-07 | The Regents Of The University Of California | Cancer biomarkers and methods of use thereof |
| US8343539B2 (en) * | 2006-07-14 | 2013-01-01 | Regents Of The University Of Minnesota | Compounds that bind α5β1 integrin and methods of use |
| KR100813262B1 (ko) * | 2006-07-25 | 2008-03-13 | 삼성전자주식회사 | 광 촉매를 이용한 패터닝된 스팟 마이크로어레이의 제조방법 및 상기 방법에 의해 제조된 마이크로어레이 |
| WO2008015645A2 (en) * | 2006-08-02 | 2008-02-07 | Koninklijke Philips Electronics N.V. | A method of determining the concentration of an analyte using analyte sensor molecules coupled to a porous membrane |
| GB0617429D0 (en) | 2006-09-05 | 2006-10-18 | Electrophoretics Ltd | Markers of renal transplant rejection and renal damage |
| JP5994121B2 (ja) | 2006-09-07 | 2016-09-21 | オタゴ イノベーション リミテッド | バイオマーカー |
| US8658573B2 (en) * | 2006-09-11 | 2014-02-25 | The Trustees Of Columbia University In The City Of New York | Photo-generated carbohydrate arrays and the rapid identification of pathogen-specific antigens and antibodies |
| WO2008039774A1 (en) | 2006-09-25 | 2008-04-03 | Mayo Foundation For Medical Education And Research | Extracellular and membrane-associated prostate cancer markers |
| US20090087925A1 (en) * | 2007-10-01 | 2009-04-02 | Zyomyx, Inc. | Devices and methods for analysis of samples with depletion of analyte content |
| US20080085512A1 (en) * | 2006-10-05 | 2008-04-10 | D Andrade Petula N | Array assay devices and methods for making and using the same |
| JP5143841B2 (ja) * | 2006-10-10 | 2013-02-13 | ロス アラモス ナショナル セキュリティー,エルエルシー | 高度な薬物開発及び製造 |
| DK2074230T3 (da) * | 2006-10-11 | 2013-02-25 | Janssen Pharmaceutica Nv | Sammensætninger og fremgangsmåder til behandling og diagnosticering af colon irritabile |
| US20080167532A1 (en) * | 2006-10-13 | 2008-07-10 | Mayo Foundation For Medical Education And Research | Assessing cancer treatment responsiveness |
| CA2667992A1 (en) * | 2006-10-31 | 2008-05-08 | Sru Biosystems, Inc. | Method for blocking non-specific protein binding on a functionalized surface |
| JP2008171800A (ja) * | 2006-10-31 | 2008-07-24 | Fei Co | 荷電粒子ビーム処理用保護層 |
| WO2008058018A2 (en) | 2006-11-02 | 2008-05-15 | Mayo Foundation For Medical Education And Research | Predicting cancer outcome |
| WO2008070570A2 (en) * | 2006-12-01 | 2008-06-12 | Cedars-Sinai Medical Center | Positive selection of serum proteins for proteomic analysis |
| US8029902B2 (en) * | 2006-12-11 | 2011-10-04 | Wisconsin Alumni Research Foundation | Plasma-enhanced functionalization of substrate surfaces with quaternary ammonium and quaternary phosphonium groups |
| NZ594510A (en) * | 2006-12-27 | 2012-06-29 | Harvard College | Compositions and methods for the treatment of infections and tumors |
| KR100894419B1 (ko) * | 2006-12-29 | 2009-04-24 | 삼성전자주식회사 | 바이오칩 키트 및 바이오 시료의 검사 방법 |
| EP2629094A1 (en) | 2007-01-24 | 2013-08-21 | Carnegie Mellon University | Optical biosensors |
| US20090053690A1 (en) * | 2007-02-02 | 2009-02-26 | California Institute Of Technology | Surface chemistry and deposition techniques |
| US7867783B2 (en) | 2007-02-22 | 2011-01-11 | Maven Technologies, Llc | Apparatus and method for performing ligand binding assays on microarrays in multiwell plates |
| TW200837349A (en) * | 2007-03-07 | 2008-09-16 | Nat Univ Tsing Hua | Biochip and manufacturing method thereof |
| US8399047B2 (en) | 2007-03-22 | 2013-03-19 | The Regents Of The Univeristy Of Michigan | Multifunctional CVD coatings |
| JP4850855B2 (ja) * | 2007-03-22 | 2012-01-11 | 信越化学工業株式会社 | マイクロアレイ作製用基板の製造方法 |
| JP2010522882A (ja) | 2007-03-27 | 2010-07-08 | ヴァーミリオン インコーポレイテッド | 卵巣癌のバイオマーカー |
| US20080242559A1 (en) * | 2007-03-28 | 2008-10-02 | Northwestern University | Protein and peptide arrays |
| JP5656339B2 (ja) * | 2007-03-28 | 2015-01-21 | Jsr株式会社 | タンパク質固定化担体およびその製造方法 |
| US7863037B1 (en) | 2007-04-04 | 2011-01-04 | Maven Technologies, Llc | Ligand binding assays on microarrays in closed multiwell plates |
| US8093039B2 (en) | 2007-04-10 | 2012-01-10 | The Trustees Of The Stevens Institute Of Technology | Surfaces differentially adhesive to eukaryotic cells and non-eukaryotic cells |
| AU2008242664B2 (en) * | 2007-04-19 | 2011-10-20 | Sru Biosystems, Inc. | Method for employing a biosensor to detect small molecules that bind directly to immobilized targets |
| WO2008128333A1 (en) * | 2007-04-19 | 2008-10-30 | The Governors Of The University Of Alberta | A method to distinguish antibody-mediated tissue rejection from t cell-mediated tissue rejection |
| US20080274458A1 (en) * | 2007-05-01 | 2008-11-06 | Latham Gary J | Nucleic acid quantitation methods |
| US20110091377A1 (en) | 2007-05-11 | 2011-04-21 | The Johns Hopkins University | Biomarkers for melanoma |
| US20090041633A1 (en) * | 2007-05-14 | 2009-02-12 | Dultz Shane C | Apparatus and method for performing ligand binding assays on microarrays in multiwell plates |
| WO2008143351A1 (en) * | 2007-05-18 | 2008-11-27 | Fujirebio Inc. | Chemical surface nanopatterns to increase activity of surface-immobilized biomolecules |
| US7799558B1 (en) | 2007-05-22 | 2010-09-21 | Dultz Shane C | Ligand binding assays on microarrays in closed multiwell plates |
| JP5661457B2 (ja) * | 2007-06-06 | 2015-01-28 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッドSiemens Healthcare Diagnostics Inc. | 腎疾患の予測診断 |
| KR100927886B1 (ko) * | 2007-06-18 | 2009-11-23 | 한국생명공학연구원 | 단백질 g-올리고 뉴클레오타이드 결합체 |
| CA3056116A1 (en) | 2007-06-22 | 2008-12-31 | Randolph Watnick | Methods and uses thereof of prosaposin |
| US20100291563A1 (en) * | 2007-06-29 | 2010-11-18 | Halloran Philip F | Assessing tissue rejection |
| WO2009009718A1 (en) * | 2007-07-11 | 2009-01-15 | Sru Biosystems, Inc. | Methods of identifying modulators of ion channels |
| US9134307B2 (en) | 2007-07-11 | 2015-09-15 | X-Body, Inc. | Method for determining ion channel modulating properties of a test reagent |
| CA2694112A1 (en) * | 2007-07-20 | 2009-01-29 | The University Of Utah Research Foundation | Identification and quantification of biomarkers for evaluating the risk of preterm birth |
| DE102007034993A1 (de) * | 2007-07-26 | 2009-01-29 | Hanna Diehl | Lösliches Cadherin 17 für die Diagnose und Risikostratifizierung von Darmtumor oder Darmkrebs |
| US20090060786A1 (en) * | 2007-08-29 | 2009-03-05 | Gibum Kim | Microfluidic apparatus for wide area microarrays |
| WO2009033056A1 (en) | 2007-09-06 | 2009-03-12 | Bioscale, Inc. | Reusable detection surfaces and methods of using same |
| DK2195428T3 (en) | 2007-09-19 | 2014-03-03 | Applied Biosystems Llc | SIRNA SEQUENCE-INDEPENDENT MODIFICATION FORMS TO REDUCE TARGET-FAILING PHENOTYPIC EFFECTS OF RNAI, AND STABILIZED FORMS THEREOF |
| US20090087919A1 (en) | 2007-09-28 | 2009-04-02 | Caldera Pharmaceuticals, Inc. | Method and Apparatus for Measuring Protein Post-Translational Modification |
| WO2009058867A2 (en) * | 2007-10-29 | 2009-05-07 | Primorigen Biosciences, Llc | Affinity measurements using frameless multiplexed microarrays |
| CA2707182C (en) * | 2007-11-30 | 2017-12-12 | Siemens Healthcare Diagnostics Inc. | Adiponectin receptor fragments and methods of use |
| US8004669B1 (en) | 2007-12-18 | 2011-08-23 | Plexera Llc | SPR apparatus with a high performance fluid delivery system |
| US20090181857A1 (en) * | 2008-01-15 | 2009-07-16 | Academia Sinica | System and method for producing a label-free micro-array biochip |
| KR100959831B1 (ko) | 2008-01-18 | 2010-05-28 | 포항공과대학교 산학협력단 | 패턴인식형 다중생물분자 검출판 |
| US20090196852A1 (en) * | 2008-02-04 | 2009-08-06 | Watkinson D Tobin | Compositions and methods for diagnosing and treating immune disorders |
| DE102008011850A1 (de) * | 2008-02-29 | 2009-09-03 | Michael Grzendowski | Biomarker für die Diagnose von Hirntumor |
| US20110160070A1 (en) | 2008-03-10 | 2011-06-30 | Lineagen, Inc. | Copd biomarker signatures |
| EP2265641B1 (en) | 2008-03-12 | 2018-01-24 | Otago Innovation Limited | Biomarkers |
| WO2009113880A1 (en) | 2008-03-12 | 2009-09-17 | Christopher Joseph Pemberton | Biomarkers |
| EP2260305A1 (en) * | 2008-03-27 | 2010-12-15 | INSERM (Institut National de la Santé et de la Recherche Medicale) | Methods and kits for determining the occurrence of a liver disease in a subject |
| US20110092686A1 (en) * | 2008-03-28 | 2011-04-21 | Pelican Group Holdings, Inc. | Multicapillary sample preparation devices and methods for processing analytes |
| US8257936B2 (en) * | 2008-04-09 | 2012-09-04 | X-Body Inc. | High resolution label free analysis of cellular properties |
| US20090286692A1 (en) * | 2008-04-15 | 2009-11-19 | Wainwright Norman R | Cartridge and Method for Sample Analysis |
| US20090263905A1 (en) * | 2008-04-18 | 2009-10-22 | Kim Scheuringer | Detection test assembly for detecting the presence of a substance in a sample |
| EP2899209A1 (en) | 2008-04-29 | 2015-07-29 | Abbvie Inc. | Dual Variable Domain Immunoglobulins and uses thereof |
| US8039270B2 (en) * | 2008-05-22 | 2011-10-18 | Maven Technologies, Llc | Apparatus and method for performing ligand binding assays on microarrays in multiwell plates |
| US7981664B1 (en) | 2008-05-22 | 2011-07-19 | Maven Technologies, Llc | Apparatus and method for performing ligand binding assays on microarrays in multiwell plates |
| AU2009253675A1 (en) | 2008-05-28 | 2009-12-03 | Genomedx Biosciences, Inc. | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
| US10407731B2 (en) | 2008-05-30 | 2019-09-10 | Mayo Foundation For Medical Education And Research | Biomarker panels for predicting prostate cancer outcomes |
| US20090298082A1 (en) * | 2008-05-30 | 2009-12-03 | Klee George G | Biomarker panels for predicting prostate cancer outcomes |
| BRPI0913406A2 (pt) | 2008-06-03 | 2018-01-09 | Abbott Lab | imunoglobulinas de domínio variável duplo e usos das mesmas |
| WO2009149285A1 (en) * | 2008-06-04 | 2009-12-10 | Sru Biosystems, Inc. | Detection of promiscuous small submicrometer aggregates |
| MX2010013282A (es) * | 2008-06-04 | 2010-12-21 | Talecris Biotherapeutics Inc | Composicion, metodo y kit para la preparacion de plasmina. |
| WO2009158704A2 (en) | 2008-06-27 | 2009-12-30 | Duke University | Therapeutic agents comprising elastin-like peptides |
| US8021850B2 (en) * | 2008-07-14 | 2011-09-20 | Ribo Guo | Universal tandem solid-phases based immunoassay |
| WO2010123608A2 (en) | 2009-01-29 | 2010-10-28 | The Regents Of The University Of California | A spatial biomarker of disease and detection of spatial organization of cellular recptors |
| US8476008B2 (en) * | 2008-07-23 | 2013-07-02 | Diabetomics, Llc | Methods for detecting pre-diabetes and diabetes |
| JP5781436B2 (ja) | 2008-08-11 | 2015-09-24 | バンヤン・バイオマーカーズ・インコーポレーテッド | 神経学的状態のバイオマーカー検出方法およびアッセイ |
| EP2340300B1 (en) | 2008-09-24 | 2013-12-18 | Straus Holdings Inc. | Method for detecting analytes |
| CN102301002A (zh) | 2008-11-12 | 2011-12-28 | 卡里斯生命科学卢森堡控股有限责任公司 | 使用外来体来确定表现型的方法和系统 |
| SI2370593T1 (sl) * | 2008-11-28 | 2016-08-31 | Emory University | Postopek za določanje učinkovitosti antagonista pd-1 |
| JP4911639B2 (ja) * | 2008-12-02 | 2012-04-04 | 学校法人早稲田大学 | バイオセンシング方法及び固定化方法 |
| US8349325B2 (en) | 2008-12-23 | 2013-01-08 | Abbott Laboratories | Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making |
| WO2010078403A2 (en) | 2008-12-30 | 2010-07-08 | Lipella Pharmaceuticals Inc. | Methods and compositions for diagnosing urological disorders |
| KR20110110247A (ko) | 2008-12-30 | 2011-10-06 | 센토코 오르토 바이오테크 인코포레이티드 | 강직성 척추염 환자에서 항-TNFα 항체에 대한 임상적 반응을 예측하는 혈청 마커 |
| CA2750818A1 (en) | 2009-01-27 | 2010-08-05 | Proteogenix, Inc. | Biomarkers for detection of neonatal sepsis in biological fluid |
| WO2010087985A2 (en) | 2009-01-28 | 2010-08-05 | Yale University | Novel markers for detection of complications resulting from in utero encounters |
| US9958442B2 (en) | 2009-02-11 | 2018-05-01 | Duke University | Sensors incorporating antibodies and methods of making and using the same |
| PL2403865T3 (pl) | 2009-03-03 | 2016-01-29 | Grifols Therapeutics Inc | Sposoby wytwarzania plazminogenu |
| TW201613969A (en) | 2009-03-05 | 2016-04-16 | Abbvie Inc | IL-17 binding proteins |
| EP2409155A1 (en) | 2009-03-15 | 2012-01-25 | Technion Research and Development Foundation, Ltd. | Soluble hla complexes for use in disease diagnosis |
| CN102388308B (zh) | 2009-04-23 | 2015-08-19 | 西门子医疗保健诊断公司 | 单体和二聚形式的脂连蛋白受体片段和使用方法 |
| WO2010125566A2 (en) | 2009-04-27 | 2010-11-04 | Technion Research And Development Foundation Ltd. | Markers for cancer detection |
| US20100273185A1 (en) * | 2009-04-27 | 2010-10-28 | Sru Biosystems, Inc. | Detection of Biased Agonist Activation |
| EP2424971A4 (en) * | 2009-05-01 | 2013-07-31 | Univ Utah Res Found | METHOD AND COMPOSITIONS FOR MEASURING HIGH AFFAIR INTERACTIONS WITH KINETIC IMAGING OF A SINGLE MOLECULAR ACTION (KISMI) |
| WO2010132890A1 (en) * | 2009-05-15 | 2010-11-18 | Sru Biosystems, Inc | Detection of changes in cell populations and mixed cell populations |
| US20100303835A1 (en) * | 2009-05-29 | 2010-12-02 | The Board Of Regents Of The University Of Texas System | Peptoid ligands for isolation and treatment of autoimmune t-cells |
| KR20120122869A (ko) * | 2009-06-02 | 2012-11-07 | 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 | 신경변성 질환을 갖는 대상에서 항체에 의해 인식되는 소분자의 확인법 |
| US20120190574A1 (en) * | 2009-06-19 | 2012-07-26 | The Arizona Board of Regents, A body Corporate of the State of Arizona for and on behalf of Arizona | Compound Arrays for Sample Profiling |
| GB0912231D0 (en) * | 2009-07-14 | 2009-08-26 | Imp Innovations Ltd | Method and apparatus for determining an analyte parameter |
| US8685755B2 (en) * | 2009-07-20 | 2014-04-01 | The Board Of Regents Of The University Of Texas System | Combinatorial multidomain mesoporous chips and a method for fractionation, stabilization, and storage of biomolecules |
| HUE054744T2 (hu) | 2009-08-14 | 2021-12-28 | Phasebio Pharmaceuticals Inc | Módosított vazoaktív intesztinális peptidek |
| WO2011036297A2 (de) | 2009-09-27 | 2011-03-31 | Ruhr-Universität-Bochum | Verfahren zur therapie und diagnose von morbus alzheimer |
| WO2011047257A1 (en) * | 2009-10-16 | 2011-04-21 | The Board Of Regents Of The University Of Texas System | Compositions and methods for producing cyclic peptoid libraries |
| KR101105328B1 (ko) * | 2009-11-23 | 2012-01-16 | 한국표준과학연구원 | 분자 흡착 및 해리 동특성 측정장치 및 측정방법 |
| ES2677944T3 (es) | 2009-11-25 | 2018-08-07 | Hologic Inc. | Detección de infección intraamniótica |
| AU2010339794B2 (en) | 2009-12-17 | 2016-09-22 | Children's Medical Center Corporation | Saposin-A derived peptides and uses thereof |
| US8355133B2 (en) * | 2009-12-30 | 2013-01-15 | Maven Technologies, Llc | Biological testing with sawtooth-shaped prisms |
| AU2011205230A1 (en) | 2010-01-13 | 2012-08-02 | Caris Life Sciences Switzerland Holdings Gmbh | Detection of gastrointestinal disorders |
| US9682132B2 (en) | 2010-01-26 | 2017-06-20 | Banyan Biomarkers, Inc | Compositions and methods relating to argininosucccinate synthetase |
| CA2791905A1 (en) | 2010-03-01 | 2011-09-09 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Biomarkers for theranostics |
| WO2011112993A2 (en) | 2010-03-11 | 2011-09-15 | University Of Louisville Research Foundation, Inc. | Methods of predicting and decreasing the risk of pregnancy loss |
| US20110229921A1 (en) * | 2010-03-18 | 2011-09-22 | Abbott Laboratories | METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS |
| WO2011120042A1 (en) * | 2010-03-26 | 2011-09-29 | Sru Biosystems, Inc. | Use of induced pluripotent cells and other cells for screening compound libraries |
| CA2795776A1 (en) | 2010-04-06 | 2011-10-13 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Circulating biomarkers for disease |
| EP3508854A1 (en) | 2010-04-27 | 2019-07-10 | The Regents of The University of California | Cancer biomarkers and methods of use thereof |
| US8841417B2 (en) | 2010-05-14 | 2014-09-23 | Abbvie Inc. | IL-1 binding proteins |
| US9211542B2 (en) * | 2010-05-21 | 2015-12-15 | Eidgenossische Technische Hochschule Zurich | High-density sample support plate for automated sample aliquoting |
| WO2011163558A1 (en) | 2010-06-25 | 2011-12-29 | Abbott Laboratories | Materials and methods for assay of anti-hepatitis c virus (hcv) antibodies |
| WO2012006500A2 (en) | 2010-07-08 | 2012-01-12 | Abbott Laboratories | Monoclonal antibodies against hepatitis c virus core protein |
| UY33492A (es) | 2010-07-09 | 2012-01-31 | Abbott Lab | Inmunoglobulinas con dominio variable dual y usos de las mismas |
| CN103140498B (zh) | 2010-07-19 | 2017-05-17 | 奥塔哥创新有限公司 | 信号生物标志物 |
| KR101045209B1 (ko) * | 2010-07-26 | 2011-06-30 | 삼성전자주식회사 | 고정화 영역을 갖는 포토레지스트 막을 포함하는 어레이 장치 및 이를 이용한 표적 물질 검출방법 |
| TW201206473A (en) | 2010-08-03 | 2012-02-16 | Abbott Lab | Dual variable domain immunoglobulins and uses thereof |
| CA2812194C (en) | 2010-09-17 | 2022-12-13 | President And Fellows Of Harvard College | Functional genomics assay for characterizing pluripotent stem cell utility and safety |
| WO2012051519A2 (en) | 2010-10-14 | 2012-04-19 | The Johns Hopkins University | Biomarkers of brain injury |
| US20120115244A1 (en) | 2010-11-09 | 2012-05-10 | Abbott Laboratories | Materials and methods for immunoassay of pterins |
| US20130267443A1 (en) | 2010-11-19 | 2013-10-10 | The Regents Of The University Of Michigan | ncRNA AND USES THEREOF |
| CN102486474B (zh) * | 2010-12-06 | 2014-05-28 | 北京大学人民医院 | 干扰素治疗慢性丙型肝炎转归预测蛋白芯片 |
| KR20130133247A (ko) | 2010-12-21 | 2013-12-06 | 애브비 인코포레이티드 | Il-1-알파 및 -베타 이특이적 이원 가변 도메인 면역글로불린 및 이의 용도 |
| JP2014510526A (ja) | 2011-03-15 | 2014-05-01 | ユニヴァーシティー オブ ユタ リサーチ ファウンデーション | 血管関連黄斑症およびその症状の診断および治療方法 |
| US8735175B2 (en) | 2011-03-18 | 2014-05-27 | Chris D. Geddes | Multicolor microwave-accelerated metal-enhanced fluorescence (M-MAMEF) |
| US9291616B2 (en) | 2011-04-08 | 2016-03-22 | The General Hospital Corporation | Fungal-derived carbohydrate-conjugated scaffold |
| AU2012242684B2 (en) | 2011-04-15 | 2017-04-20 | Children's Medical Center Corporation | Diagnostic markers and therapeutic targets of Kawasaki disease |
| KR101158362B1 (ko) | 2011-04-20 | 2012-06-22 | 한국과학기술원 | 세포 환경 내에서의 단일 분자 수준의 단백질-단백질 상호작용 분석 방법 |
| JP2014518624A (ja) | 2011-05-12 | 2014-08-07 | ザ・ジョンズ・ホプキンス・ユニバーシティー | ニューログラニン診断キットのためのアッセイ試薬 |
| EP2717902B1 (en) | 2011-06-06 | 2018-01-24 | Phasebio Pharmaceuticals, Inc. | Use of modified vasoactive intestinal peptides in the treatment of hypertension |
| JP5202761B2 (ja) * | 2011-06-10 | 2013-06-05 | パナソニック株式会社 | 抗体を自己組織化膜上に固定する方法 |
| EP2718715B1 (en) * | 2011-06-13 | 2018-12-26 | InDevR, Inc. | Low density microarrays for vaccine related protein quantification, potency determination and efficacy evaluation |
| CN102279261B (zh) * | 2011-06-20 | 2013-09-18 | 东南大学 | 一种图案编码微载体的喷墨打印制备方法 |
| JP2014527036A (ja) | 2011-06-27 | 2014-10-09 | ザ ジャクソン ラボラトリー | 癌および自己免疫疾患の処置のための方法および組成物 |
| WO2013005269A1 (ja) * | 2011-07-05 | 2013-01-10 | パナソニック株式会社 | アルブミンを自己組織化膜上に固定する方法 |
| JPWO2013008280A1 (ja) * | 2011-07-08 | 2015-02-23 | パナソニックヘルスケア株式会社 | タンパク質を自己組織化膜上に固定する方法 |
| US20140235492A1 (en) * | 2011-09-20 | 2014-08-21 | Institut National De La Sante Et De La Recherche Medicate (Inserm) | Methods for preparing single domain antibody microarrays |
| WO2013055829A1 (en) * | 2011-10-11 | 2013-04-18 | Nestec S.A. | Proximity-based assays for the detection of signaling protein expression and activation |
| HK1200321A1 (en) | 2011-10-24 | 2015-08-07 | Abbvie Inc. | Bispecific immunobinders directed against tnf and il-17 |
| CN104203978A (zh) | 2011-10-24 | 2014-12-10 | 艾伯维股份有限公司 | 针对硬化蛋白的免疫结合剂 |
| DK2776550T3 (en) | 2011-11-07 | 2018-02-19 | Rapid Micro Biosystems Inc | Cartridge for sterility testing |
| CA2855640C (en) | 2011-11-14 | 2020-03-10 | The General Hospital Corporation | Assays and methods for selecting a treatment regimen for a subject with depression |
| CA2858581A1 (en) | 2011-12-13 | 2013-06-20 | Genomedx Biosciences, Inc. | Cancer diagnostics using non-coding transcripts |
| EP4306123A3 (en) | 2011-12-22 | 2024-04-17 | Children's Medical Center Corporation | Saposin-a derived peptides and uses thereof |
| US8993248B2 (en) | 2011-12-31 | 2015-03-31 | Abbott Laboratories | Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use |
| NZ629074A (en) | 2012-01-20 | 2016-09-30 | Adelaide Res & Innovation Pty | Biomarkers for gastric cancer and uses thereof |
| DK2828282T3 (en) | 2012-03-20 | 2018-03-05 | Otago Innovation Ltd | Biomarkers |
| WO2013158666A1 (en) | 2012-04-16 | 2013-10-24 | Rapid Micro Biosystems, Inc. | Cell culturing device |
| WO2014001459A1 (en) | 2012-06-29 | 2014-01-03 | Danmarks Tekniske Universitet | A method of charging a test carrier and a test carrier |
| UY34905A (es) | 2012-07-12 | 2014-01-31 | Abbvie Inc | Proteínas de unión a il-1 |
| US11035005B2 (en) | 2012-08-16 | 2021-06-15 | Decipher Biosciences, Inc. | Cancer diagnostics using biomarkers |
| WO2014028907A1 (en) | 2012-08-16 | 2014-02-20 | The Trustees Of Columbia University In The City Of New York | Diagnostic markers of indolent prostate cancer |
| ES2912033T3 (es) | 2012-10-23 | 2022-05-24 | Caris Science Inc | Aptámeros y usos de los mismos |
| US10942184B2 (en) | 2012-10-23 | 2021-03-09 | Caris Science, Inc. | Aptamers and uses thereof |
| US20150330993A1 (en) | 2012-11-08 | 2015-11-19 | The Macfarlane Burnet Institute For Medical Research And Public Health Ltd | Diagnostic, prognostic, therapeutic and screening protocols |
| EP2935628B1 (en) | 2012-12-19 | 2018-03-21 | Caris Life Sciences Switzerland Holdings GmbH | Compositions and methods for aptamer screening |
| AU2013202668B2 (en) | 2012-12-24 | 2014-12-18 | Adelaide Research & Innovation Pty Ltd | Inhibition of cancer growth and metastasis |
| US9086412B2 (en) | 2012-12-31 | 2015-07-21 | University Of Louisville Research Foundation, Inc. | Extracellular vesicle-associated protein markers of cancer |
| US9194873B2 (en) | 2013-03-14 | 2015-11-24 | Abbott Laboratories | HCV antigen-antibody combination assay and methods and compositions for use therein |
| WO2014143343A1 (en) | 2013-03-14 | 2014-09-18 | Abbott Laboratories | Hcv core lipid binding domain monoclonal antibodies |
| WO2014143342A1 (en) | 2013-03-14 | 2014-09-18 | Abbott Laboratories | Hcv ns3 recombinant antigens and mutants thereof for improved antibody detection |
| US9005901B2 (en) | 2013-03-15 | 2015-04-14 | Abbott Laboratories | Assay with internal calibration |
| US9157910B2 (en) | 2013-03-15 | 2015-10-13 | Abbott Laboratories | Assay with increased dynamic range |
| CA2914918C (en) | 2013-05-10 | 2023-10-10 | Johns Hopkins University | Compositions and methods for ovarian cancer assessment having improved specificity |
| DE102013210138A1 (de) | 2013-05-30 | 2014-12-04 | Boehringer Ingelheim Vetmedica Gmbh | Verfahren zum Erzeugen einer Vielzahl von Messbereichen auf einem Chip sowie Chip mit Messbereichen |
| JP2014235115A (ja) | 2013-06-04 | 2014-12-15 | ウシオ電機株式会社 | マイクロチップおよびマイクロチップにおける金属薄膜の成膜方法 |
| EP3022322A4 (en) | 2013-07-17 | 2017-05-17 | The Johns Hopkins University | A multi-protein biomarker assay for brain injury detection and outcome |
| CN105980615A (zh) | 2013-08-28 | 2016-09-28 | 卡里斯生命科学瑞士控股有限公司 | 寡核苷酸探针及其用途 |
| CA2940653A1 (en) | 2014-02-27 | 2015-09-03 | Vijay Kuchroo | T cell balance gene expression, compositions of matters and methods of use thereof |
| WO2015187227A2 (en) | 2014-03-13 | 2015-12-10 | Duke University | Electronic platform for sensing and control of electrochemical reactions |
| ES2818824T3 (es) | 2014-05-08 | 2021-04-14 | Phasebio Pharmaceuticals Inc | Composiciones que comprenden una proteína de fusión de VIP-ELP para su uso en el tratamiento de fibrosis quística |
| EP3916390A1 (en) | 2014-06-04 | 2021-12-01 | Indevr, Inc. | Universal capture array for multiplexed subtype-specific quantification and stability determination of influenza proteins |
| EP3158086B1 (en) | 2014-06-19 | 2021-03-24 | Memorial Sloan-Kettering Cancer Center | Biomarkers for response to ezh2 inhibitors |
| US9694518B2 (en) | 2014-06-20 | 2017-07-04 | The Regents Of The University Of Michigan | Breath-activated images and anti-counterfeit authentication features formed of nanopillar arrays |
| EP3161490B1 (en) | 2014-06-27 | 2019-10-02 | Abbott Laboratories | Compositions and methods for detecting human pegivirus 2 (hpgv-2) |
| WO2016011383A1 (en) | 2014-07-17 | 2016-01-21 | The Trustees Of The University Of Pennsylvania | Methods for using exosomes to monitor transplanted organ status |
| US20160032281A1 (en) * | 2014-07-31 | 2016-02-04 | Fei Company | Functionalized grids for locating and imaging biological specimens and methods of using the same |
| WO2016044697A1 (en) | 2014-09-19 | 2016-03-24 | The Johns Hopkins University | Biomarkers of cognitive dysfunction |
| CN107110868B (zh) | 2014-10-29 | 2020-08-21 | 雅培制药有限公司 | 采用ns3捕获肽的受试者抗hcv抗体检测测定 |
| KR101687950B1 (ko) * | 2014-11-14 | 2016-12-21 | 연세대학교 산학협력단 | 표면 개질된 진단용 플레이트, 상기 표면 개질된 진단용 플레이트의 제조방법, 및 상기 표면 개질된 진단용 플레이트를 이용한 진단 방법 |
| EP3224380A1 (en) | 2014-11-25 | 2017-10-04 | The Broad Institute Inc. | Clonal haematopoiesis |
| EP3224381B1 (en) | 2014-11-25 | 2019-09-04 | The Brigham and Women's Hospital, Inc. | Method of identifying a person having a predisposition to or afflicted with a cardiometabolic disease |
| EP3227687A4 (en) | 2014-12-05 | 2018-10-24 | Prelude, Inc. | Dcis recurrence and invasive breast cancer |
| US10545158B2 (en) * | 2014-12-29 | 2020-01-28 | North Carolina State University | Multiplexed diagnostic to recognize concentrations of related proteins and peptides |
| CN114652817A (zh) | 2015-02-09 | 2022-06-24 | 费斯生物制药公司 | 用于治疗肌肉疾病和病症的方法和组合物 |
| EP3259594A4 (en) | 2015-02-20 | 2018-12-26 | The Johns Hopkins University | Biomarkers of myocardial injury |
| EP3262193A2 (en) | 2015-02-26 | 2018-01-03 | The Broad Institute Inc. | T cell balance gene expression, compositions of matters and methods of use thereof |
| CN107533069A (zh) * | 2015-03-06 | 2018-01-02 | 泰摩拉分析运营有限责任公司 | 用于分析蛋白修饰的化学上官能化的阵列 |
| AU2016229076B2 (en) | 2015-03-09 | 2022-01-20 | Caris Science, Inc. | Oligonucleotide probes and uses thereof |
| US10294451B2 (en) | 2015-04-22 | 2019-05-21 | University Of Maryland, Baltimore County | Flow and static lysing systems and methods for ultra-rapid isolation and fragmentation of biological materials by microwave irradiation |
| IL256634B2 (en) | 2015-06-29 | 2025-08-01 | Caris Science Inc | Therapeutic oligonucleotides |
| CN108291330A (zh) | 2015-07-10 | 2018-07-17 | 西弗吉尼亚大学 | 卒中和卒中严重性的标志物 |
| WO2017015531A1 (en) | 2015-07-22 | 2017-01-26 | University Of Maryland, Baltimore County | Hydrophilic coatings of plasmonic metals to enable low volume metal-enhanced fluorescence |
| US10941176B2 (en) | 2015-07-28 | 2021-03-09 | Caris Science, Inc. | Therapeutic oligonucleotides |
| DE102015114026A1 (de) | 2015-08-24 | 2017-03-02 | Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V. | Biomarker-Panel für die Diagnose von rezidivem Prostatakrebs |
| US10758886B2 (en) | 2015-09-14 | 2020-09-01 | Arizona Board Of Regents On Behalf Of Arizona State University | Conditioned surfaces for in situ molecular array synthesis |
| US11884978B2 (en) | 2015-09-30 | 2024-01-30 | Immunexpress Pty Ltd | Pathogen biomarkers and uses therefor |
| US10730071B2 (en) | 2015-12-02 | 2020-08-04 | Boehringer Ingelheim Vetmedica Gmbh | Method for producing a plurality of measurement regions on a chip, and chip having a plurality of measurement regions |
| WO2017099829A1 (en) | 2015-12-11 | 2017-06-15 | The General Hospital Corporation | Compositions and methods for treating drug-tolerant glioblastoma |
| WO2017106918A1 (en) | 2015-12-24 | 2017-06-29 | Immunexpress Pty Ltd | Triage biomarkers and uses therefor |
| EP4339288A3 (en) | 2016-03-18 | 2024-06-05 | Caris Science, Inc. | Oligonucleotide probes and uses thereof |
| US11293017B2 (en) | 2016-05-25 | 2022-04-05 | Caris Science, Inc. | Oligonucleotide probes and uses thereof |
| CA3028975A1 (en) | 2016-06-20 | 2017-12-28 | Healthtell Inc. | Methods for diagnosis and treatment of autoimmune diseases |
| CA3028960A1 (en) | 2016-06-20 | 2017-12-28 | Healthtell Inc. | Methods for differential diagnosis of autoimmune diseases |
| US11414708B2 (en) | 2016-08-24 | 2022-08-16 | Decipher Biosciences, Inc. | Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy |
| CN110366558A (zh) | 2016-10-28 | 2019-10-22 | 班扬生物标记公司 | 针对泛素c末端水解酶l1(uch-l1)和胶质纤维酸性蛋白(gfap)的抗体及相关方法 |
| WO2018089858A1 (en) | 2016-11-11 | 2018-05-17 | Healthtell Inc. | Methods for identifying candidate biomarkers |
| WO2018089764A1 (en) | 2016-11-11 | 2018-05-17 | Ascendant Dx, Llc | Compositions and methods for diagnosing and differentiating systemic juvenile idiopathic arthritis and kawasaki disease |
| EP3571322B9 (en) | 2017-01-20 | 2023-10-04 | VERACYTE SD, Inc. | Molecular subtyping, prognosis, and treatment of bladder cancer |
| EP3593140A4 (en) | 2017-03-09 | 2021-01-06 | Decipher Biosciences, Inc. | Subtyping prostate cancer to predict response to hormone therapy |
| US20200131576A1 (en) | 2017-04-25 | 2020-04-30 | The Brigham And Women's Hospital, Inc. | IL-8, IL-6, IL-1 Beta and TET2 and DNMT3A in Atherosclerosis |
| CA3062716A1 (en) | 2017-05-12 | 2018-11-15 | Decipher Biosciences, Inc. | Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness |
| EP4428157A3 (en) | 2017-08-04 | 2024-12-11 | Veracyte SD, Inc. | Use of immune cell-specific gene expression for prognosis of prostate cancer and prediction of responsiveness to radiation therapy |
| EP3669004A1 (en) | 2017-08-16 | 2020-06-24 | Medimmune, LLC | Compositions and methods for treatment of atopic dermatitis and treatment selection |
| US12025615B2 (en) | 2017-09-15 | 2024-07-02 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods of classifying response to immunotherapy for cancer |
| US11709156B2 (en) | 2017-09-18 | 2023-07-25 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved analytical analysis |
| US12181452B2 (en) | 2017-09-18 | 2024-12-31 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes |
| US12180581B2 (en) | 2017-09-18 | 2024-12-31 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes |
| US11709155B2 (en) | 2017-09-18 | 2023-07-25 | Waters Technologies Corporation | Use of vapor deposition coated flow paths for improved chromatography of metal interacting analytes |
| WO2019094798A1 (en) | 2017-11-10 | 2019-05-16 | The Trustees Of Columbia University In The City Of New York | Methods and compositions for promoting or inducing hair growth |
| WO2019161491A1 (en) | 2018-02-20 | 2019-08-29 | Prominent Medical Inc. | Aluminum oxide surfaces and interface molecules |
| AU2019255388B2 (en) | 2018-04-19 | 2025-01-30 | First Light Diagnostics, Inc. | Detection of targets |
| JP7371019B2 (ja) | 2018-05-10 | 2023-10-30 | ザ・メソジスト・ホスピタル | 疾病の予後と管理のための方法 |
| WO2019236632A1 (en) | 2018-06-04 | 2019-12-12 | Avon Products. Inc. | Protein biomarkers for identifying and treating aging skin and skin conditions |
| US20220187301A1 (en) | 2018-09-14 | 2022-06-16 | Prelude Corporation | Method of selection for treatment of subjects at risk of invasive breast cancer |
| EP3861357A4 (en) | 2018-10-04 | 2022-11-09 | First Light Diagnostics, Inc. | Test cartridges |
| AU2019374692B2 (en) | 2018-11-07 | 2025-08-28 | Seer, Inc. | Compositions, methods and systems for protein corona analysis and uses thereof |
| EP3930867B1 (en) | 2019-02-27 | 2025-11-12 | Waters Technologies Corporation | Chromatographic seal and coated flow paths for minimizing analyte adsorption |
| GB201904697D0 (en) | 2019-04-03 | 2019-05-15 | Vib Vzw | Means and methods for single molecule peptide sequencing |
| CA3146525A1 (en) | 2019-08-05 | 2021-02-11 | William Manning | Systems and methods for sample preparation, data generation, and protein corona analysis |
| WO2021067550A1 (en) | 2019-10-02 | 2021-04-08 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods and compositions for identifying neoantigens for use in treating and preventing cancer |
| US12018279B2 (en) | 2019-10-18 | 2024-06-25 | The Trustees Of The University Of Pennsylvania | Micro-engineered models of the human eye and methods of use |
| US11918936B2 (en) | 2020-01-17 | 2024-03-05 | Waters Technologies Corporation | Performance and dynamic range for oligonucleotide bioanalysis through reduction of non specific binding |
| EP4185301A4 (en) | 2020-07-24 | 2025-05-07 | The Regents Of The University Of Michigan | Compositions and methods for detecting and treating high grade subtypes of uterine cancer |
| CN116391122A (zh) | 2020-09-24 | 2023-07-04 | 沃特世科技公司 | 用于反应性分子分离的色谱硬件改进 |
| US20230375552A1 (en) | 2020-09-29 | 2023-11-23 | The Johns Hopkins University | Integrated proteomic biomarkers for the detection of aggressive prostate cancer |
| EP4074820A1 (en) | 2021-04-16 | 2022-10-19 | The Trustees of The University of Pennsylvania | Micro-engineered models of the human eye and methods of use |
| US20240353400A1 (en) * | 2021-07-16 | 2024-10-24 | The University Of Chicago | Biocompatible surface for quantum sensing and methods thereof |
| WO2023122723A1 (en) | 2021-12-23 | 2023-06-29 | The Broad Institute, Inc. | Panels and methods for diagnosing and treating lung cancer |
| US20240068941A1 (en) * | 2022-08-24 | 2024-02-29 | Miami University | Label-free bacterial detection |
| WO2024184407A1 (en) | 2023-03-06 | 2024-09-12 | Vib Vzw | Method for identifying tumor-specific cell surface o-glycopeptides |
| WO2025106804A1 (en) | 2023-11-16 | 2025-05-22 | Massachusetts Institute Of Technology | Compositions and methods for characterizing hepatocyte stress |
| WO2025217069A1 (en) | 2024-04-08 | 2025-10-16 | Beth Israel Deaconess Medical Center, Inc. | Compositions and methods for treating cardiotoxicity |
Family Cites Families (163)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4071409A (en) | 1976-05-20 | 1978-01-31 | Corning Glass Works | Immobilization of proteins on inorganic support materials |
| US4722896A (en) | 1981-01-26 | 1988-02-02 | The Beth Israel Hospital Association | Method for affinity purification of hybridoma antibodies |
| US4444879A (en) * | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
| US4690715A (en) | 1982-06-18 | 1987-09-01 | American Telephone And Telegraph Company, At&T Bell Laboratories | Modification of the properties of metals |
| US4514508A (en) * | 1982-07-06 | 1985-04-30 | Biond Inc. | Assaying for a multiplicity of antigens or antibodies with a detection compound |
| US4973493A (en) | 1982-09-29 | 1990-11-27 | Bio-Metric Systems, Inc. | Method of improving the biocompatibility of solid surfaces |
| US4994373A (en) * | 1983-01-27 | 1991-02-19 | Enzo Biochem, Inc. | Method and structures employing chemically-labelled polynucleotide probes |
| US4591570A (en) * | 1983-02-02 | 1986-05-27 | Centocor, Inc. | Matrix of antibody-coated spots for determination of antigens |
| US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8314523D0 (en) | 1983-05-25 | 1983-06-29 | Lowe C R | Diagnostic device |
| US4608112A (en) * | 1984-05-16 | 1986-08-26 | The United States Of America As Represented By The Secretary Of The Air Force | Mask aligner for solar cell fabrication |
| AU600885B2 (en) | 1984-05-25 | 1990-08-30 | Zymogenetics Inc. | Stable DNA constructs |
| US5096807A (en) | 1985-03-06 | 1992-03-17 | Murex Corporation | Imaging immunoassay detection system with background compensation and its use |
| US5523215A (en) * | 1985-03-28 | 1996-06-04 | Chiron Corporation | Enhanced purification and expression of insoluble recombinant proteins |
| US5866363A (en) * | 1985-08-28 | 1999-02-02 | Pieczenik; George | Method and means for sorting and identifying biological information |
| US4894146A (en) * | 1986-01-27 | 1990-01-16 | University Of Utah | Thin channel split flow process and apparatus for particle fractionation |
| US4802951A (en) * | 1986-03-07 | 1989-02-07 | Trustees Of Boston University | Method for parallel fabrication of nanometer scale multi-device structures |
| US5643948A (en) * | 1986-06-11 | 1997-07-01 | Procyon Pharmaceuticals, Inc. | Protein kinase C modulators. K. |
| US5637489A (en) * | 1986-08-23 | 1997-06-10 | Hoechst Aktiengesellschaft | Phosphinothricin-resistance gene, and its use |
| US4859538A (en) | 1986-11-20 | 1989-08-22 | Ribi Hans O | Novel lipid-protein compositions and articles and methods for their preparation |
| US5079600A (en) | 1987-03-06 | 1992-01-07 | Schnur Joel M | High resolution patterning on solid substrates |
| US4928112A (en) * | 1987-03-23 | 1990-05-22 | Howtek, Inc. | Ink curing apparatus |
| US5154808A (en) | 1987-06-26 | 1992-10-13 | Fuji Photo Film Co., Ltd. | Functional organic thin film and process for producing the same |
| US4987032A (en) | 1987-06-26 | 1991-01-22 | Fuji Photo Film Co., Ltd. | Functional organic thin film and method of manufacture thereof |
| DE3733190A1 (de) * | 1987-10-01 | 1989-04-13 | Kugelfischer G Schaefer & Co | Mehrreihiges kugel- oder rollenlager bzw. kombiniertes kugel-rollenlager |
| US6692751B1 (en) * | 1988-05-06 | 2004-02-17 | New York Blood Center | Methods and systems for producing recombinant viral antigens |
| US4908112A (en) | 1988-06-16 | 1990-03-13 | E. I. Du Pont De Nemours & Co. | Silicon semiconductor wafer for analyzing micronic biological samples |
| US5281540A (en) * | 1988-08-02 | 1994-01-25 | Abbott Laboratories | Test array for performing assays |
| US5720928A (en) * | 1988-09-15 | 1998-02-24 | New York University | Image processing and analysis of individual nucleic acid molecules |
| SE462454B (sv) | 1988-11-10 | 1990-06-25 | Pharmacia Ab | Maetyta foer anvaendning i biosensorer |
| JPH02272081A (ja) * | 1989-04-14 | 1990-11-06 | Fuji Photo Film Co Ltd | 機能性有機薄膜 |
| IT1229691B (it) | 1989-04-21 | 1991-09-06 | Eniricerche Spa | Sensore con antigene legato chimicamente a un dispositivo semiconduttore. |
| US5424186A (en) * | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5800992A (en) * | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US6346413B1 (en) * | 1989-06-07 | 2002-02-12 | Affymetrix, Inc. | Polymer arrays |
| US5252743A (en) * | 1989-11-13 | 1993-10-12 | Affymax Technologies N.V. | Spatially-addressable immobilization of anti-ligands on surfaces |
| DE3939973A1 (de) | 1989-12-02 | 1991-06-06 | Basf Ag | Zweidimensional kristallisierte makromolekuelschichten |
| US5283173A (en) * | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
| US5858188A (en) | 1990-02-28 | 1999-01-12 | Aclara Biosciences, Inc. | Acrylic microchannels and their use in electrophoretic applications |
| WO1991016425A1 (de) | 1990-04-12 | 1991-10-31 | Hans Sigrist | Verfahren zur lichtinduzierten immobilisierung von biomolekülen an chemisch 'inerten' oberflächen |
| US5861254A (en) * | 1997-01-31 | 1999-01-19 | Nexstar Pharmaceuticals, Inc. | Flow cell SELEX |
| US5665582A (en) * | 1990-10-29 | 1997-09-09 | Dekalb Genetics Corp. | Isolation of biological materials |
| WO1992008788A1 (en) * | 1990-11-19 | 1992-05-29 | The Board Of Trustees Of The University Of Illinois | Mutant orientable proteins and coated substrates |
| US5294369A (en) | 1990-12-05 | 1994-03-15 | Akzo N.V. | Ligand gold bonding |
| EP0834576B1 (en) * | 1990-12-06 | 2002-01-16 | Affymetrix, Inc. (a Delaware Corporation) | Detection of nucleic acid sequences |
| US5384886A (en) * | 1991-04-01 | 1995-01-24 | Xerox Corporation | Process for electronically printing envelopes |
| US5763170A (en) * | 1991-04-16 | 1998-06-09 | Amersham International Plc | Method for forming an array of biological particles |
| JP3097866B2 (ja) * | 1991-10-15 | 2000-10-10 | マルティライト リミティド | 標識試薬を使用した結合検定法 |
| US5605662A (en) | 1993-11-01 | 1997-02-25 | Nanogen, Inc. | Active programmable electronic devices for molecular biological analysis and diagnostics |
| US6051380A (en) * | 1993-11-01 | 2000-04-18 | Nanogen, Inc. | Methods and procedures for molecular biological analysis and diagnostics |
| IL103674A0 (en) * | 1991-11-19 | 1993-04-04 | Houston Advanced Res Center | Method and apparatus for molecule detection |
| EP0916396B1 (en) | 1991-11-22 | 2005-04-13 | Affymetrix, Inc. (a Delaware Corporation) | Combinatorial strategies for polymer synthesis |
| US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
| US5412087A (en) | 1992-04-24 | 1995-05-02 | Affymax Technologies N.V. | Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces |
| WO1993011236A1 (en) * | 1991-12-02 | 1993-06-10 | Medical Research Council | Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| EP0544969B1 (de) | 1991-12-06 | 1997-03-05 | Ciba-Geigy Ag | Elektrophoretische Trennvorrichtung und elektrophoretisches Trennverfahren |
| CA2064683A1 (en) | 1992-03-26 | 1993-09-27 | Krishna Mohan Rao Kallury | Formation of thermostable enzymes with extra-ordinary heat tolerance by immobilization on phospholipid matrices |
| ATE143730T1 (de) | 1992-04-22 | 1996-10-15 | Ecole Polytech | Lipidmembranen fur biosensoranwendungen |
| US5304487A (en) | 1992-05-01 | 1994-04-19 | Trustees Of The University Of Pennsylvania | Fluid handling in mesoscale analytical devices |
| US5637469A (en) | 1992-05-01 | 1997-06-10 | Trustees Of The University Of Pennsylvania | Methods and apparatus for the detection of an analyte utilizing mesoscale flow systems |
| US5726026A (en) | 1992-05-01 | 1998-03-10 | Trustees Of The University Of Pennsylvania | Mesoscale sample preparation device and systems for determination and processing of analytes |
| JPH0641183A (ja) | 1992-07-23 | 1994-02-15 | Mitsubishi Kasei Corp | オリゴヌクレオチド単分子膜 |
| DE4237113B4 (de) * | 1992-11-03 | 2006-10-12 | "Iba Gmbh" | Peptide und deren Fusionsproteine, Expressionsvektor und Verfahren zur Herstellung eines Fusionsproteins |
| CA2108705A1 (en) * | 1992-11-06 | 1994-05-07 | Richard Barner | Biologically recognizing layers on new ti02 waveguide for biosensors |
| US5472881A (en) | 1992-11-12 | 1995-12-05 | University Of Utah Research Foundation | Thiol labeling of DNA for attachment to gold surfaces |
| US5532142A (en) * | 1993-02-12 | 1996-07-02 | Board Of Regents, The University Of Texas System | Method of isolation and purification of fusion polypeptides |
| US5512492A (en) | 1993-05-18 | 1996-04-30 | University Of Utah Research Foundation | Waveguide immunosensor with coating chemistry providing enhanced sensitivity |
| US5677196A (en) | 1993-05-18 | 1997-10-14 | University Of Utah Research Foundation | Apparatus and methods for multi-analyte homogeneous fluoro-immunoassays |
| ATE242485T1 (de) | 1993-05-28 | 2003-06-15 | Baylor College Medicine | Verfahren und massenspektrometer zur desorption und ionisierung von analyten |
| US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
| US5861242A (en) | 1993-06-25 | 1999-01-19 | Affymetrix, Inc. | Array of nucleic acid probes on biological chips for diagnosis of HIV and methods of using the same |
| EP0711303B2 (en) * | 1993-07-30 | 2009-06-10 | Affymax, Inc. | Biotinylation of proteins |
| US5441876A (en) | 1993-07-30 | 1995-08-15 | The United States Of America As Represented By The Secretary Of The Navy | Process for the preparation of headgroup-modified phospholipids using phosphatidylhydroxyalkanols as intermediates |
| RU2041262C1 (ru) * | 1993-08-11 | 1995-08-09 | Институт молекулярной биологии им.В.А.Энгельгардта РАН | Способ иммобилизации водорастворимых биоорганических соединений на капиллярно-пористый носитель |
| JPH0784372A (ja) | 1993-09-17 | 1995-03-31 | Res Dev Corp Of Japan | 有機シラン修飾酸化物と修飾表面 光パターニング酸化物 |
| DE4332003C2 (de) | 1993-09-21 | 1996-02-22 | Seeger Stefan | Verfahren zur Beschichtung von Oberflächen mit Biomolekülen und anderen Rezeptormolekülen |
| US5512131A (en) | 1993-10-04 | 1996-04-30 | President And Fellows Of Harvard College | Formation of microstamped patterns on surfaces and derivative articles |
| CA2174140C (en) * | 1993-10-28 | 2004-04-06 | Kenneth L. Beattie | Microfabricated, flowthrough porous apparatus for discrete detection of binding reactions |
| US5429708A (en) | 1993-12-22 | 1995-07-04 | The Board Of Trustees Of The Leland Stanford Junior University | Molecular layers covalently bonded to silicon surfaces |
| EP0664452B1 (de) * | 1994-01-19 | 2002-07-31 | Roche Diagnostics GmbH | Biotinsilan-Verbindungen und diese Verbindungen enthaltende Bindematrix |
| DE4435728A1 (de) * | 1994-01-19 | 1995-07-20 | Boehringer Mannheim Gmbh | Biotinsilan-Verbindungen und diese Verbindungen enthaltende Bindematrix |
| US5594111A (en) * | 1994-01-28 | 1997-01-14 | Prolinx, Inc. | Phenylboronic acid complexes for bioconjugate preparation |
| US5623055A (en) * | 1994-01-28 | 1997-04-22 | Prolinx, Inc. | Phenylboronic acid complexes derived from aminosalicylic acid for bioconjugate preparation |
| WO1995022051A1 (en) | 1994-02-09 | 1995-08-17 | Abbott Laboratories | Diagnostic flow cell device |
| US5514501A (en) | 1994-06-07 | 1996-05-07 | The United States Of America As Represented By The Secretary Of Commerce | Process for UV-photopatterning of thiolate monolayers self-assembled on gold, silver and other substrates |
| US6287850B1 (en) * | 1995-06-07 | 2001-09-11 | Affymetrix, Inc. | Bioarray chip reaction apparatus and its manufacture |
| US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
| WO1996002830A1 (en) | 1994-07-14 | 1996-02-01 | Technobiochip | Biosensor and method and instrument for deposition of alternating monomolecular layers |
| US5498545A (en) * | 1994-07-21 | 1996-03-12 | Vestal; Marvin L. | Mass spectrometer system and method for matrix-assisted laser desorption measurements |
| SE9403245D0 (sv) | 1994-09-26 | 1994-09-26 | Pharmacia Biosensor Ab | Improvements relating to bilayer lipid membranes |
| US5620850A (en) | 1994-09-26 | 1997-04-15 | President And Fellows Of Harvard College | Molecular recognition at surfaces derivatized with self-assembled monolayers |
| US5571410A (en) | 1994-10-19 | 1996-11-05 | Hewlett Packard Company | Fully integrated miniaturized planar liquid sample handling and analysis device |
| US5603351A (en) | 1995-06-07 | 1997-02-18 | David Sarnoff Research Center, Inc. | Method and system for inhibiting cross-contamination in fluids of combinatorial chemistry device |
| US5585069A (en) | 1994-11-10 | 1996-12-17 | David Sarnoff Research Center, Inc. | Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis |
| US5688642A (en) | 1994-12-01 | 1997-11-18 | The United States Of America As Represented By The Secretary Of The Navy | Selective attachment of nucleic acid molecules to patterned self-assembled surfaces |
| US5622826A (en) | 1994-12-22 | 1997-04-22 | Houston Advanced Research Center | Method for immobilization of molecules on platinum solid support surfaces |
| US5814565A (en) | 1995-02-23 | 1998-09-29 | University Of Utah Research Foundation | Integrated optic waveguide immunosensor |
| WO1996029629A2 (en) | 1995-03-01 | 1996-09-26 | President And Fellows Of Harvard College | Microcontact printing on surfaces and derivative articles |
| US5629213A (en) | 1995-03-03 | 1997-05-13 | Kornguth; Steven E. | Analytical biosensor |
| JPH11503005A (ja) | 1995-03-08 | 1999-03-23 | アクゾ ノーベル ナムローゼ フェンノートシャップ | 表面修飾されたアフィニティ分離膜 |
| US6140045A (en) * | 1995-03-10 | 2000-10-31 | Meso Scale Technologies | Multi-array, multi-specific electrochemiluminescence testing |
| JPH11502617A (ja) * | 1995-03-10 | 1999-03-02 | メソ スケール テクノロジーズ,エルエルシー | 多重アレイの多重特異的な電気化学発光試験 |
| US6309820B1 (en) * | 1995-04-07 | 2001-10-30 | University Of North Carolina At Chapel Hill | Polypeptides having a functional domain of interest and methods of identifying and using same |
| US5624711A (en) * | 1995-04-27 | 1997-04-29 | Affymax Technologies, N.V. | Derivatization of solid supports and methods for oligomer synthesis |
| US5625184A (en) * | 1995-05-19 | 1997-04-29 | Perseptive Biosystems, Inc. | Time-of-flight mass spectrometry analysis of biomolecules |
| US5700642A (en) | 1995-05-22 | 1997-12-23 | Sri International | Oligonucleotide sizing using immobilized cleavable primers |
| WO1996038726A1 (en) | 1995-05-30 | 1996-12-05 | Ecole Polytechnique Federale De Lausanne (Epfl) | Covalently immobilized phospholipid bilayers on solid surfaces |
| US5776674A (en) | 1995-06-05 | 1998-07-07 | Seq, Ltd | Chemical biochemical and biological processing in thin films |
| US5545531A (en) * | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
| WO1996039937A1 (en) | 1995-06-07 | 1996-12-19 | The Regents Of The University Of California | Microfabricated devices for diagnostic applications |
| US6720149B1 (en) * | 1995-06-07 | 2004-04-13 | Affymetrix, Inc. | Methods for concurrently processing multiple biological chip assays |
| WO1997007429A1 (en) | 1995-08-18 | 1997-02-27 | President And Fellows Of Harvard College | Self-assembled monolayer directed patterning of surfaces |
| ATE272058T1 (de) * | 1995-10-17 | 2004-08-15 | Combichem Inc | Matrize für die synthese kombinatorischer bibliotheken in lösung |
| DE19543232A1 (de) | 1995-11-07 | 1997-05-15 | Knoell Hans Forschung Ev | Herstellung einer Matrix-gebundenen miniaturisierten kombinatorischen Poly- und Oligomerbibliothek |
| US5763263A (en) * | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| ES2223067T3 (es) | 1995-12-01 | 2005-02-16 | Innogenetics N.V. | Sistema de deteccion impedimetrico y metodo de produccion del mismo. |
| DE19548152A1 (de) | 1995-12-22 | 1997-06-26 | Boehringer Mannheim Gmbh | Verfahren zur Bedeckung einer Oberfläche mit einem Film eines Oligoethylenglykolderivates |
| AU723909B2 (en) | 1996-03-15 | 2000-09-07 | President And Fellows Of Harvard College | Method of forming articles and patterning surfaces via capillary micromolding |
| US6126899A (en) | 1996-04-03 | 2000-10-03 | The Perkins-Elmer Corporation | Device for multiple analyte detection |
| US5942443A (en) | 1996-06-28 | 1999-08-24 | Caliper Technologies Corporation | High throughput screening assay systems in microscale fluidic devices |
| US5925552A (en) | 1996-04-25 | 1999-07-20 | Medtronic, Inc. | Method for attachment of biomolecules to medical devices surfaces |
| EP1005644B1 (en) | 1996-04-25 | 2003-03-12 | Pence, Inc. | Biosensor device and method |
| US6165335A (en) | 1996-04-25 | 2000-12-26 | Pence And Mcgill University | Biosensor device and method |
| US5731152A (en) | 1996-05-13 | 1998-03-24 | Motorola, Inc. | Methods and systems for biological reagent placement |
| US6075875A (en) * | 1996-09-30 | 2000-06-13 | Microsoft Corporation | Segmentation of image features using hierarchical analysis of multi-valued image data and weighted averaging of segmentation results |
| US20030017149A1 (en) * | 1996-10-10 | 2003-01-23 | Hoeffler James P. | Single chain monoclonal antibody fusion reagents that regulate transcription in vivo |
| WO1998023948A1 (en) | 1996-11-29 | 1998-06-04 | The Board Of Trustees Of The Leland Stanford Junior University | Arrays of independently-addressable supported fluid bilayer membranes and methods of use thereof |
| GB9624927D0 (en) * | 1996-11-29 | 1997-01-15 | Oxford Glycosciences Uk Ltd | Gels and their use |
| US5905024A (en) * | 1996-12-17 | 1999-05-18 | University Of Chicago | Method for performing site-specific affinity fractionation for use in DNA sequencing |
| US5837860A (en) | 1997-03-05 | 1998-11-17 | Molecular Tool, Inc. | Covalent attachment of nucleic acid molecules onto solid-phases via disulfide bonds |
| US6180288B1 (en) * | 1997-03-21 | 2001-01-30 | Kimberly-Clark Worldwide, Inc. | Gel sensors and method of use thereof |
| WO1998050773A2 (en) | 1997-05-08 | 1998-11-12 | University Of Minnesota | Microcantilever biosensor |
| US6190619B1 (en) * | 1997-06-11 | 2001-02-20 | Argonaut Technologies, Inc. | Systems and methods for parallel synthesis of compounds |
| NZ516848A (en) * | 1997-06-20 | 2004-03-26 | Ciphergen Biosystems Inc | Retentate chromatography apparatus with applications in biology and medicine |
| US5948621A (en) * | 1997-09-30 | 1999-09-07 | The United States Of America As Represented By The Secretary Of The Navy | Direct molecular patterning using a micro-stamp gel |
| US6548021B1 (en) * | 1997-10-10 | 2003-04-15 | President And Fellows Of Harvard College | Surface-bound, double-stranded DNA protein arrays |
| US6061476A (en) * | 1997-11-24 | 2000-05-09 | Cognex Corporation | Method and apparatus using image subtraction and dynamic thresholding |
| US6232066B1 (en) * | 1997-12-19 | 2001-05-15 | Neogen, Inc. | High throughput assay system |
| AU2583899A (en) | 1998-02-04 | 1999-08-23 | Invitrogen Corporation | Microarrays and uses therefor |
| US6087103A (en) * | 1998-03-04 | 2000-07-11 | Lifespan Biosciences, Inc. | Tagged ligand arrays for identifying target-ligand interactions |
| EP1073893A4 (en) * | 1998-04-14 | 2002-07-03 | California Inst Of Techn | METHOD AND SYSTEM FOR DETECTING THE ACTIVITY OF AN ANALYTE |
| US6287765B1 (en) * | 1998-05-20 | 2001-09-11 | Molecular Machines, Inc. | Methods for detecting and identifying single molecules |
| US6682942B1 (en) * | 1998-07-14 | 2004-01-27 | Zyomyx, Inc. | Microdevices for screening biomolecules |
| US6576478B1 (en) * | 1998-07-14 | 2003-06-10 | Zyomyx, Inc. | Microdevices for high-throughput screening of biomolecules |
| US20020119579A1 (en) * | 1998-07-14 | 2002-08-29 | Peter Wagner | Arrays devices and methods of use thereof |
| US6406921B1 (en) * | 1998-07-14 | 2002-06-18 | Zyomyx, Incorporated | Protein arrays for high-throughput screening |
| US6897073B2 (en) * | 1998-07-14 | 2005-05-24 | Zyomyx, Inc. | Non-specific binding resistant protein arrays and methods for making the same |
| US6197599B1 (en) * | 1998-07-30 | 2001-03-06 | Guorong Chin | Method to detect proteins |
| US6190908B1 (en) * | 1998-08-12 | 2001-02-20 | The Scripps Research Institute | Modulation of polypeptide display on modified filamentous phage |
| AU3387700A (en) | 1999-03-02 | 2000-09-21 | Chiron Corporation | Microarrays for identifying pathway activation or induction |
| AU773291B2 (en) | 1999-03-10 | 2004-05-20 | Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The | UPA, a universal protein array system |
| AU3883300A (en) | 1999-03-11 | 2000-09-28 | Combimatrix Corporation | Microarrays of peptide affinity probes for analyzing gene products and methods for analyzing gene products |
| KR100379411B1 (ko) * | 1999-06-28 | 2003-04-10 | 엘지전자 주식회사 | 바이오칩 및 그의 생체 물질 패터닝 및 측정 방법 |
| US6899137B2 (en) * | 1999-06-28 | 2005-05-31 | California Institute Of Technology | Microfabricated elastomeric valve and pump systems |
| US6406840B1 (en) * | 1999-12-17 | 2002-06-18 | Biomosaic Systems, Inc. | Cell arrays and the uses thereof |
| WO2001062887A1 (en) * | 2000-02-23 | 2001-08-30 | Zyomyx, Inc. | Chips having elevated sample surfaces |
| US6531283B1 (en) * | 2000-06-20 | 2003-03-11 | Molecular Staging, Inc. | Protein expression profiling |
| US7094568B2 (en) * | 2000-08-17 | 2006-08-22 | Sense Proteomic Ltd. | Method for producing proteins tagged at the N- or C-terminus |
| US6699665B1 (en) * | 2000-11-08 | 2004-03-02 | Surface Logix, Inc. | Multiple array system for integrating bioarrays |
| CA2467456A1 (en) * | 2001-11-19 | 2003-05-30 | Protometrix, Inc. | Method of using a non-antibody protein to detect and measure an analyte |
| US20050026215A1 (en) * | 2003-07-17 | 2005-02-03 | Predki Paul F. | Method for the prediction of an epitope |
-
1998
- 1998-07-14 US US09/115,455 patent/US6406921B1/en not_active Expired - Lifetime
-
1999
- 1999-07-14 AU AU51023/99A patent/AU773068B2/en not_active Ceased
- 1999-07-14 EP EP99935573A patent/EP1097380A1/en not_active Ceased
- 1999-07-14 WO PCT/US1999/015971 patent/WO2000004382A1/en not_active Ceased
- 1999-07-14 EP EP99935571A patent/EP1097377B1/en not_active Expired - Lifetime
- 1999-07-14 JP JP2000560449A patent/JP2002520618A/ja active Pending
- 1999-07-14 CA CA002337075A patent/CA2337075A1/en not_active Abandoned
- 1999-07-14 DE DE69938867T patent/DE69938867D1/de not_active Expired - Lifetime
- 1999-07-14 WO PCT/US1999/015968 patent/WO2000004389A2/en not_active Ceased
- 1999-07-14 US US09/353,555 patent/US6329209B1/en not_active Expired - Lifetime
- 1999-07-14 JP JP2000560456A patent/JP2002520620A/ja active Pending
- 1999-07-14 AT AT99935571T patent/ATE397752T1/de not_active IP Right Cessation
- 1999-07-14 CA CA002337654A patent/CA2337654A1/en not_active Abandoned
- 1999-07-14 AU AU51025/99A patent/AU765508B2/en not_active Ceased
- 1999-07-14 US US09/353,215 patent/US6475808B1/en not_active Expired - Fee Related
-
2000
- 2000-05-12 US US09/570,588 patent/US6475809B1/en not_active Expired - Fee Related
- 2000-05-12 US US09/570,363 patent/US6630358B1/en not_active Expired - Fee Related
- 2000-05-18 US US09/574,748 patent/US6365418B1/en not_active Expired - Lifetime
-
2002
- 2002-03-26 US US10/107,122 patent/US20030003599A1/en not_active Abandoned
- 2002-03-29 US US10/113,964 patent/US20020110933A1/en not_active Abandoned
- 2002-03-29 US US10/112,840 patent/US20020106702A1/en not_active Abandoned
-
2004
- 2004-08-04 US US10/911,945 patent/US20050008674A1/en not_active Abandoned
- 2004-08-04 US US10/911,877 patent/US20050014292A1/en not_active Abandoned
-
2006
- 2006-03-28 US US11/392,262 patent/US20060228701A1/en not_active Abandoned
-
2008
- 2008-08-15 US US12/192,321 patent/US20090131278A1/en not_active Abandoned
-
2010
- 2010-11-19 US US12/950,698 patent/US20110086779A1/en not_active Abandoned
Cited By (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005535909A (ja) * | 2002-08-16 | 2005-11-24 | ディシジョン バイオマーカーズ インコーポレイテッド | 材料の分離、反応、および顕微鏡分析のための基板 |
| JP2005312425A (ja) * | 2004-03-31 | 2005-11-10 | Toyo Kohan Co Ltd | ポリペプチドを固定化する方法、ポリペプチドが固定化されてなる固体支持体、これを用いたポリペプチドの検出方法及び精製方法、ならびにポリペプチドを固定化するための固体支持体 |
| JP2006208012A (ja) * | 2005-01-25 | 2006-08-10 | Toray Ind Inc | 選択結合性物質固定化担体 |
| JP2009510423A (ja) * | 2005-09-27 | 2009-03-12 | サントル・ナシオナル・ドゥ・ラ・ルシェルシュ・シアンティフィーク(セーエヌエールエス) | 表面プラズモン共鳴(spr)検出用の新規チップ |
| WO2007055288A1 (ja) * | 2005-11-10 | 2007-05-18 | National University Of Corporation Hiroshima University | 酸化ケイ素含有物質に結合するタンパク質を介したタンパク質の固定化方法および固定化剤 |
| US8372596B2 (en) | 2005-11-10 | 2013-02-12 | National University Of Corporation Hiroshima University | Asbestos detection method, asbestos detection agent, asbestos detection kit, method for screening candidate for agent aiming at preventing or treating disease for which asbestos is causative or worsening factor |
| JP5186689B2 (ja) * | 2005-11-10 | 2013-04-17 | 国立大学法人広島大学 | 酸化ケイ素含有物質に結合するタンパク質を介したタンパク質の固定化方法および固定化剤 |
| JP2009542203A (ja) * | 2006-06-27 | 2009-12-03 | コリア リサーチ インスティチュート オブ バイオサイエンス アンド バイオテクノロジー | システインタグ付きブドウ球菌タンパク質g変異体 |
| JP2008105973A (ja) * | 2006-10-24 | 2008-05-08 | Toyo Kohan Co Ltd | ポリペプチド固定化担体の保存方法 |
| KR100836206B1 (ko) | 2007-03-20 | 2008-06-09 | 연세대학교 산학협력단 | 패턴형성용 폴리에틸렌글리콜 하이드로젤과 이의 제조방법 |
| WO2011089903A1 (en) * | 2010-01-25 | 2011-07-28 | Panasonic Corporation | A method for immobilizing protein a on a self-assembled monolayer |
| US8980645B2 (en) | 2010-01-25 | 2015-03-17 | Panasonic Healthcare Holdings Co., Ltd. | Method for immobilizing protein A on a self-assembled monolayer |
| JP4921615B2 (ja) * | 2010-01-25 | 2012-04-25 | パナソニック株式会社 | プロテインaを自己組織化膜上に固定する方法 |
| US8785143B2 (en) | 2010-08-30 | 2014-07-22 | Panasonic Healthcare Co., Ltd. | Method for immobilizing streptavidin on a self-assembled monolayer |
| JP2012526725A (ja) * | 2010-08-30 | 2012-11-01 | パナソニック株式会社 | ストレプトアビジンを自己組織化膜上に固定する方法 |
| WO2012029202A1 (en) * | 2010-08-30 | 2012-03-08 | Panasonic Corporation | A method for immobilizing streptavidin on a self-assembled monolayer |
| JP5108166B2 (ja) * | 2010-10-19 | 2012-12-26 | パナソニック株式会社 | グルコースオキシダーゼを自己組織化膜上に固定する方法 |
| WO2012053138A1 (ja) * | 2010-10-19 | 2012-04-26 | パナソニック株式会社 | グルコースオキシダーゼを自己組織化膜上に固定する方法 |
| US8871457B2 (en) | 2010-10-19 | 2014-10-28 | Panasonic Healthcare Co., Ltd | Method for immobilizing glucose oxidase on a self-assembled monolayer |
| JP2020079788A (ja) * | 2012-02-07 | 2020-05-28 | ヴィブラント ホールディングス リミテッド ライアビリティ カンパニー | 基板、ペプチドアレイ、および方法 |
| JP2019035760A (ja) * | 2012-02-07 | 2019-03-07 | ヴィブラント ホールディングス リミテッド ライアビリティ カンパニー | 基板、ペプチドアレイ、および方法 |
| JP7098593B2 (ja) | 2012-02-07 | 2022-07-11 | ヴィブラント ホールディングス リミテッド ライアビリティ カンパニー | 基板、ペプチドアレイ、および方法 |
| US11565231B2 (en) | 2012-02-07 | 2023-01-31 | Vibrant Holdings, Llc | Substrates, peptide arrays, and methods |
| US12454771B2 (en) | 2012-02-07 | 2025-10-28 | Vibrant Holdings Llc | Substrates, peptide arrays, and methods |
| US11674956B2 (en) | 2012-09-28 | 2023-06-13 | Vibrant Holdings, Llc | Methods, systems, and arrays for biomolecular analysis |
| US11815512B2 (en) | 2012-09-28 | 2023-11-14 | Vibrant Holdings, Llc | Methods, systems, and arrays for biomolecular analysis |
| US12251674B2 (en) | 2012-11-14 | 2025-03-18 | Vibrant Holdings, Llc | Substrates, systems, and methods for array synthesis and biomolecular analysis |
| WO2018008596A1 (ja) * | 2016-07-04 | 2018-01-11 | 花王株式会社 | タンパク質解析用固相担体及びその製造方法 |
| JP2018004476A (ja) * | 2016-07-04 | 2018-01-11 | 花王株式会社 | タンパク質解析用固相担体及びその製造方法 |
| US11168365B2 (en) | 2017-05-26 | 2021-11-09 | Vibrant Holdings, Llc | Photoactive compounds and methods for biomolecule detection and sequencing |
| US12152279B2 (en) | 2017-05-26 | 2024-11-26 | Vibrant Holdings, Llc | Photoactive compounds and methods for biomolecule detection and sequencing |
| US12319712B2 (en) | 2018-05-09 | 2025-06-03 | Vibrant Holdings, Llc | Methods of synthesizing a polynucleotide array using photoactivated agents |
Also Published As
| Publication number | Publication date |
|---|---|
| AU765508B2 (en) | 2003-09-18 |
| US20090131278A1 (en) | 2009-05-21 |
| DE69938867D1 (de) | 2008-07-17 |
| US20050008674A1 (en) | 2005-01-13 |
| CA2337654A1 (en) | 2000-01-27 |
| US6630358B1 (en) | 2003-10-07 |
| US6475808B1 (en) | 2002-11-05 |
| US20020106702A1 (en) | 2002-08-08 |
| EP1097377A2 (en) | 2001-05-09 |
| US6365418B1 (en) | 2002-04-02 |
| ATE397752T1 (de) | 2008-06-15 |
| US20060228701A1 (en) | 2006-10-12 |
| WO2000004389A3 (en) | 2000-04-27 |
| US20030003599A1 (en) | 2003-01-02 |
| US20110086779A1 (en) | 2011-04-14 |
| WO2000004389A2 (en) | 2000-01-27 |
| CA2337075A1 (en) | 2000-01-27 |
| AU5102399A (en) | 2000-02-07 |
| JP2002520620A (ja) | 2002-07-09 |
| AU773068B2 (en) | 2004-05-13 |
| US6475809B1 (en) | 2002-11-05 |
| US6406921B1 (en) | 2002-06-18 |
| AU5102599A (en) | 2000-02-07 |
| US20050014292A1 (en) | 2005-01-20 |
| US6329209B1 (en) | 2001-12-11 |
| WO2000004382A1 (en) | 2000-01-27 |
| US20020110933A1 (en) | 2002-08-15 |
| EP1097377B1 (en) | 2008-06-04 |
| EP1097380A1 (en) | 2001-05-09 |
| WO2000004382A8 (en) | 2001-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002520618A (ja) | タンパク質のアレイおよびその使用方法 | |
| US6780582B1 (en) | Arrays of protein-capture agents and methods of use thereof | |
| US7247469B2 (en) | Non-specific binding resistant protein arrays and methods for making the same | |
| JP4489949B2 (ja) | 生体分子をスクリーニングするための微小デバイス | |
| US6682942B1 (en) | Microdevices for screening biomolecules | |
| US20020119579A1 (en) | Arrays devices and methods of use thereof | |
| US20090042744A1 (en) | Microdevices for screening biomolecules | |
| AU2003262452B2 (en) | Arrays of proteins and methods of use thereof I | |
| AU2004201126B2 (en) | Arrays of protein-capture agents and methods of use thereof | |
| AU2003257898A1 (en) | Microdevices for screening biomolecules | |
| CA2507754A1 (en) | Arrays of protein-capture agents and methods of use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060712 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20061122 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20061122 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20070110 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070330 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090224 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090522 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20090908 |